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Abstract
As we set out to investigate ring-closing methatesis reactions of acyloxysulfones, we
discovered that treatment with triethylamine resulted in its quantitative conversion into the γalkylidene butenolides. γ-Alkylidene Butenolides are common to a number of biologically
important natural products, and have been of great interest. To date, there has been no
metathesis-based synthesis of γ-alkylidene butenolides making our approach the first.
Development of the metathesis-based approach has allowed us to synthesize a variety of γalkylidene butenolides from the RCM products in high yields (69-100%). The elimination is
proposed to proceed via an E1cb mechanism leading to (Z)-γ-alkylidene butenolides as the major
products. In an attempt to showcase this method in the context of complex γ-alkylidene
butenolide natural products, we successfully synthesized two model spirocyclic butenolides (5,5and 6,5-). The synthesis of the model compounds will lead us one step closer in achieving the
total synthesis of a natural spiro-butenolide product.
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Chapter 1. Introduction
1.1 The Utilization of Acyloxysulfone Cross Metathesis in Polyene Synthesis
Olefin metathesis has developed as one of the most widely used carbon-carbon bondforming reactions in organic and polymer chemistry, particularly with the development of welldefined and functional group tolerant catalysts like those shown in Figure 1. Although catalysts
of this type have been successful in synthesizing a wide range of structurally diverse compounds,
there are fundamental limitations of olefin metathesis in polyene systems due to the problems
associated with chemoselectivity. Chemoselectivity is defined as the preferential outcome of one
reaction over a set of plausible reactions. In the absence of chemoselectivity, indiscriminate
metathesis occurs in the presence of multiple alkenes. Scheme 1-1 is an example of a nonchemoselective olefin metathesis reaction with no selectivity for cross metathesis,
homodimerization, or a competing ring closing metathesis.

Figure 1-1 Structures of well-defined catalysts

Scheme 1-1 Non-selective Cross Metathesis

To overcome the shortcomings accompanying poor chemoselectivity, several strategies have
been implemented including steric and/or electronic deactivation of one or more alkenes toward
metathesis. In 2004, Bouzbouz and coworkers had used steric hindrance to induce regioselective
cross metathesis by placing a bulky hydroxy protecting group in olefins of type 1 with olefins of
type 2 to produce compounds of type 3 in generally 70% yield or greater (Scheme 1-2).1
Scheme 1-2 Steric Deactivation of an Alkene

In 2004, Grubbs and coworkers had also studied the use of steric hindrance as well as
electronic deactivation for influencing chemoselectivity.2 In their study they had tried to
deactivate one of the olefins in compound 4 by attaching an electron withdrawing ester group
(Scheme 1-3).2 It was thought that by attaching an electron withdrawing group, the olefin would
no longer coordinate to the metal catalyst which is the first step in the olefin metathesis
mechanism. They found that both of the olefins in 4 were too deactivated to react with Ru-3,
whereas the more active catalyst Ru-2 reacted with both olefins to yield 6 and 7 as an 80:20
2

mixture.2 Because the ester functionality was not sufficiently deactivating when Ru-2 was used
as the catalyst, the electron density in the α,β-double bond was further reduced by introducing a
vinylic bromide at the α-carbon (Scheme 1-4). Cross-metathesis between allylbenzene 8 and 9
with Ru-2 showed that the α,β-double bond was sufficiently deactivated relative to the γ,δdouble bond to form the desired product 10 in 68% yield.2
Scheme 1-3 Electronic Deactivation of an Alkene With an Ester

Scheme 1-4 Electronic Deactivation of an Alkene by a Vinylic Bromide Introduction

Our group has been working on an alternative approach to addressing the problem of
chemoselectivity, which involves the idea of ‘masking’ one or more of the alkenes as an inert
functional group toward metathesis.3 Post-metathesis elimination of the masking elements (X and
Y) would then allow for a metathesis approach to different polyenes that have previously been
difficult to synthesize by standard metathesis technology (Scheme 1-5).4
Scheme 1-5 Proposed Masking of an Alkene

3

For this purpose, our group has been investigating the use of β-acyloxysulfones in which X is an
acyl group and Y is a sulfone (Scheme 1-6). β-acyloxysulfones are well-known intermediates in
the classical Julia olefination reaction. The Julia olefination was first described in 1973 by Julia
and Paris as an approach toward olefin synthesis in which β-acyloxysulfones were reductively
eliminated to corresponding di-, tri-, and tetra- substituted alkenes.5 The classical Julia olefination
typically occurs in three steps: (1) The first step involves the addition of an α-metallated sulfone
to an aldehyde or ketone to produce the β-hydroxysulfone. (2) The β-hydroxysulfone is then
acylated with acetic anhydride to generate the corresponding β-acetyloxysulfone. (3) Finally,
reductive elimination of both the acyl and sulfone groups with Na/Hg amalgam produces the
corresponding trans-alkene predominantly.5 More recently samarium diiodide has also been
shown to promote the β-acyloxysulfone reduction elimination.6 Originally it was assumed that
both the Na/Hg and SmI2 elimination protocols proceeded via the same mechanism.7 However
further mechanistic studies have proven this to be not entirely correct (vide infra).8
Scheme 1-6 Classical Julia Olefination

It was originally proposed that Na/Hg and SmI2 act both as a single electron donor to
produce an alkyl radical that is then further reduced to the alkyl anion.7 The anion then collapses
to produce acetate and the corresponding alkene. Volz and co-workers confirmed that SmI2 does
indeed eliminate in an analogous fashion to the original proposed route; however, they also
confirmed that it can eliminate via the route proposed by Marko in 1996.8,9 Unlike the
4

acetyloxysulfone elimination, the mechanism involves first transfer of an electron to the benzoyl
group, followed by loss of benzoate and elimination of the sulfone. Volz and co-workers found
that the route of elimination was dependent on the substrate structure, more specifically initial loss
of either the sulfonyl or benzoyl group.8 Transfer of the electron is likely reversible, and can occur
into both acceptor groups. The rate determining step occurs during formation of the carbon radical,
thus depending on the stability of the carbon radical itself; the reductive-elimination can occur
through either route.
Scheme 1-7 Accepted Mechanism for SmI2 Mediated Reductive Elimination of bacyloxysulfones

The current accepted mechanism for acyloxysulfone elimination with Na/Hg amalgam
was proposed by Keck in 1995.7 The first step involves the deprotonation of the acetoxy sulfone
leading to the vinyl sulfone. The vinyl sulfone is then reduced to the vinyl radical which is even
further reduced to a vinyl anion with sodium as a counterion. The anion is then quenched to
produce the desired alkene.

5

Scheme 1-8 Accepted Mechanism for Na/Hg Amalgam Mediated Reductive Elimination of
β-acyloxysulfones

For our purposes, we did not immediately reductively eliminate the β-acyloxysulfones.
Rather, our intention was to investigate their use as masked alkenes in metathesis reactions to
provide access to polyenes that would otherwise be difficult to synthesize by olefin metathesis
(Scheme 1-9). Prior to my own work, the focus had been on cross-metathesis reactions of
acyloxysulfones, exemplified by the total synthesis of haminol A (Scheme 1-10).10 Since both
the cross-metathesis reaction and subsequent acyloxysulfone elimination with either Na/Hg or
SmI2 lead to the formation of trans-alkenes, this approach is limited to synthesis of all-trans
polyenes.
Scheme 1-9 Synthesis of Polyene Subunits Using β-acyloxysulfone Cross Metathesis

6

Scheme 1-10 Synthesis of haminol A

Many natural products, however, include both cis- and trans- olefins such as macrolactin A
(Figure 1-2). To further extend the scope of these β-acyloxysulfones as masked alkene
intermediates, we set out to investigate incorporation of cis-alkenes by using RCM. RCM
stereoselectivity is dependent on the catalyst, ring strain, and starting diene. Z-isomers
predominate in smaller rings as the more stable product because it allows for the minimization of
ring strain; whereas macrocycles tend to favor E-isomers as it is more thermodynamically
stable.11 To achieve the cis-alkene we would therefore target smaller rings such as cyclopentenes
and cyclohexenes for our RCM.

Figure 1-2 Natural Product macrolactin A
1.2 Proposed Route Towards the Synthesis of E/Z-Dienoic Acid
Similar to the use of acyloxysulfones in cross metathesis, β-acyloxysulfone RCM
substrates would be synthesized via two complementary methods as outlined in Scheme 1-11, βacyloxysulfones would then undergo RCM to give cis-alkene containing products. With the cis-

7

alkene formed, it was envisioned that reductive elimination of the acyloxysulfone with either
SmI2 or Na/Hg amalgam would produce the corresponding E,Z-dienoic acid 23 (Scheme 1-12).
Scheme 1-11 Complementary Methods for Synthesizing Acyloxysulfones

Scheme 1-12 E,Z-Dienoic Acid Synthesis by Ring-Closing Metathesis/Elimination

1.3 Unexpected Synthesis of γ-Alkylidenebutenolides
Our initial investigations began with the synthesis of compounds of type 18 and 20
(Scheme 1-11). One approach involved the addition of lithiated (allylsulfonyl)benzene 17 to
benzaldehyde , followed by an in situ acylation with acryloyl chloride affording the dienylacyloxysulfone 18 in 55% yield. The complementary approach involved the addition of lithiated
benzyl phenyl sulfone 19 to acrolein followed by acylation with acryloyl chloride to obtain the
8

acyloxysulfone in 64% yield. An RCM was then performed on the resulting β-acyloxysulfones
using Ru-2 as the catalyst (Table 1-1). After several failed attempts to get the six-membered ring
to close from compound 18a, we decided to focus solely on the five-membered ring. The first
attempt at an RCM on the β-acyloxysulfone 20a gave only a 10% yield, after several attempts to
optimize the conditions, we found that the RCM gave the highest yield when toluene was the
solvent, the temperature was at 80 °C, and 3 batches of 2.5 mole % of the catalyst was added in 6
hour intervals.
Table 1-1 Optimization of β-acyloxysulfone RCM

Substrate
18a
18a
20a
20a
20a

Cat.
(mol%)
10
10
5
5
3 x 2.5

Solvent
Toluene
Toluene
DCM
Toluene
Toluene

Temp
(°C)
60
80
45
60
80

Yield
0%
0%
10%
15%
64%

As originally proposed, several reductive elimination conditions including the use of
Na/Hg amalgam and SmI2 were then examined to try and achieve the desired E,Z- dienoic acid
which is common to a number of important natural products including the previously mentioned
macrolactin A (Figure 1-1). After numerous attempts, all that was obtained under various
conditions with both reagents was a complex mixture of products and no indication of the
desired E,Z-dienoic acid (Scheme 1-12). Unsuccessful with the reductive eliminations, we then
set out to investigate a sequential elimination.

9

Scheme 1-12 Reductive Elimination of RCM Product with SmI2 or Na/Hg Amalgam

The acyl-group would be eliminated first, followed by a reductive cleavage of the
resulting vinyl sulfone. This was based on previous work from Keck et al. who had performed
similar reactions in which a number vinyl sulfones were prepared by the elimination of acetoxy
sulfones with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) followed by the use of SmI2 to
reductively cleave the vinyl sulfone (Scheme 1-13).7 To that end, our RCM product 22a was
treated with DBU at room temperature and left to stir overnight in an attempt to produce vinyl
sulfone 27 (Scheme 1-14). After obtaining a 1H NMR spectrum of the crude product mixture, it
was concluded that this reaction did not produce the desired vinyl sulfone but it also had
completely destroyed the starting material. In a second attempt to produce the vinyl sulfone,
TEA, a milder base was used in place of DBU. From the crude 1H NMR there was potential that
we had made the desired vinyl sulfone 27, uncertain, the sample was sent off for a mass spectral
analysis. Receiving the mass spectrum there was a clear molecular ion peak at m/z =172,
unfortunately the vinyl sulfone we were expecting has a molecular weight of 314. From the mass
spectrum combined with the 1H NMR, it was concluded that elimination with TEA had not
produced vinyl sulfone 27. TEA had instead eliminated the phenyl sulfone making the
unexpected γ-alkylidenebutenolide 28.

10

Scheme 1-13 Sequential Elimination with DBU and SmI2

Scheme 1-14 Unexpected Synthesis of γ-alkylidenebutenolide

α,β-Unsaturated γ-lactones with the alkylidene substituent in the γ- position (i.e. γalkylidenebutenolides) are in fact of great interest. Many biologically active molecules contain
this structural motif, most often with the exocyclic Cγ=C bond possessing the Z-configuration.12
Our acyloxysulfone RCM/elimination sequence therefore provided a novel method for the
preparation of this important class of compounds.

11

Chapter 2. Biological Importance and Previous Syntheses of γ-Alkylidenebutenolide
2.1 Biological Importance of γ-Alkylidene Butenolides
Butenolides and their analogues represent a wide range of natural compounds that have
both medicinal and biological importance. Biologically active γ-alkylidene butenolide-containing
natural products include the rubrolides, nostoclides, uncinine and pulvinones (Figure 2-1).12 These
natural products display various biological activities including antibacterial, anticancer, antibiotic
and phospholipase A2 inhibition activity.12 The simplest representation of a compound of this type
is γ-methylenebutenolide, a natural product known as protoanemonin which is known to be an
antibiotic (Figure 2-1).13 Some highly unsaturated representations of γ-alkylidenebutenolide are
dihydroxerulin and xerulin (Figure 2-1).14 These compounds were isolated as 90:10-65:35
mixtures from Xerula melanotrichaand and were found to inhibit the biosynthesis of cholesterol
without being cytotoxic.

Figure 2-1. Representative examples of γ-alkylidenebutenolides

Figure 2-2. Varying structures of γ-alkylidenebutenolides

12

Recently there has been a strong interest in glucosidase inhibitors, which has led to many
types of natural and synthetic inhibitors. This interest ultimately aided in discovering the
mechanism by which glucosidase acts and the development of potential pharmaceuticals such as
anti-tumor agents, anti-viral agents, and immunoregulatory agents.15 Searching for glucosidase
inhibitors led Xu and co-workers to the discovery of some andrographolide derivatives which wer
proven to be potent and specific α-glucosidase inhibitors.15 Due to some glucosidase inhibitors
showing anti-tumor metastasis and anti-HIV activities as well as clinically proven to help treat
diabetes, Xu and co-workers studied andrographolide in depth in hopes of synthesizing a new and
stronger glucosidase inhibitor. Andrographolides contain three important structures: (1) an αalkylidene-γ-butyrolactone moiety, (2) two double bonds ∆8(17) and ∆12(13), (3) three hydroxyls at
C-3, C-19, and C-14; andrographolide derivatives were synthesized by modification of the above
structural features.15 The results indicated that the γ-alkylidene butenolide moiety and the aromatic
group at 3,19-hydroxyls favored α-glucosidase inhibitory activity. Of the 15 derivatives,
compounds 29 and 30 were the best α-glucosidase inhibitors with an IC50 value of 16 μM and 6
μM, both containing the γ-alkylidene butenolide moiety (Figure 2-3). Due to the significance of
the γ-alkylidene butenolide moiety in these biologically active compounds, it is important to
explore different routes toward synthesizing this moiety. The following sections will discuss
different approaches towards synthesizing γ-alkylidene butenolides.

13

Figure 2-3. Most active andrographolide derivatives for α-glucosidase inhibition
2 .2 Alkylidenation of Five-Membered Oxygen-Containing Heterocycles
The most widely used strategy for synthesizing γ-alkylidenebutenolides is the
alkylidenation of five-membered oxygen-containing heterocycles. In 2000, Bruckner and coworkers had stereoselectively synthesized freelingyne 35 and related γ-alkylidenebutenolides by
Mukaiyama aldol additions between siloxyfurans and suitable aldehydes.16 Stephens-Castro
couplings of the resulting butenolides followed by anti-elimination of water provided freelynge
35 and associated γ-alkylidenebutenolides in good yield and selectivity.16 Although the
Mukaiyama aldol addition reaction coupled with the Stephens-Castro coupling results in good
yield and selectivity for the γ-alkylidenebutenolides, the starting aldehydes 31 and siloxyfurans
32 themselves require additional steps usually resulting in mediocre to poor yields (Scheme 22).16

14

Scheme 2-1 Synthesis of freelingyne

Scheme 2-2 Synthesis of 31 and 32

An alternative strategy to synthesizing γ-alkylidenebutenolides involves a HornerEmmons reaction with butenolides as shown in Scheme 2-3. In 2001, David and co-workers had
developed a short and practical route to the tricyclic core of an unnatural pseudopterosin
diastereomer.17 Key features of their approach involved an arene alkylation with γ-alkylidene
butenolide followed by an elaborate reduction sequence. Synthesis of the intermediate γalkylidene butenolide was achieved through a Horner-Emmons reaction with butenolide 41 and
aldehyde 38 affording intermediate 42 in high yields.
15

Scheme 2-3 Synthesizing γ-alkylidenebutenolides via a Horner Emmons Reaction

Starting from a maleic anhydride derivative, γ-alkylidenebutenolides can also be
achieved by nucleophilic addition of an organometallic reagent followed by a Wittig
condensation and base-catalyzed rearrangement. Babu and co-workers had discovered the
antifungal lead coruscanone A (Figure 2-4) from the ethanol extract of the piperaceous plant
Piper coruscans in the midst of searching for a prototype antifungal agent from natural sources.18
Coruscanone A showed strong antifungal activity against two major pathogens C. albicans and
C. neoformans associated with immunocompromised patients (AIDS, cancer, or organ
transplant). In addition, coruscanone A had displayed acceptable in vitro cytotoxicity against
mammalian Vero cells.18 In order to develop a robust pharmacophoric model and to better
understand the mechanism for which coruscanone A acts as an antifungal agent, its structural
moieties were modified independently in order to facilitate the systematic refinement of the
search for increasingly effective analogues. One of the structural features of coruscanone A
includes the γ-alkylidenebutenolide moiety. Preparation of the analogues began with a Wittig
condensation with a maleic anhydride derivative 43 and phosphorene 44 achieving the γalkylidenebutenolide intermediate 45 (Scheme 2-4). The phosphoranes were prepared from the
corresponding α-methyl ketone in a three-step sequence via brominated α-methyl ketone and
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phosphonium salt. Although preparation of the phosphoranes were generally high, the
preparation of the bromoethyl ketones and phosphonium salt themselves ranged anywhere from
56-90%, generally on the lower side of that scale.18 Following the Wittig condensation was a
base-catalyzed rearrangement of the resulting 4-ylidenebutenolide, making the corresponding
cyclopentenedione. The enolic hydroxyl-substituted product was then achieved followed by an
alkylation or acylation.

Figure 2-4 Coruscanone A
Scheme 2-4 Synthesizing γ-alkylidenebutenolides via a Wittig Condensation

2.3 Cyclization of γ-oxoacids
Pd-catalyzed C,C-couplings between alkenes or organo-metallic compounds and alkenyl
or aryl halides or triflates have become crucial in organic synthesis.19 Investigating these
couplings led Sorg and co-workers towards developing a novel method for synthesizing γalkylidenebutenolides stereoselectively in 2003.20 gem-Dibromoolefin and 1,3-dibromo’diene’
were prepared from readily available dibromolevulinic acid by treatment with 2:1 concentrated
17

H2SO4/oleum and concentrated H2SO4. A single isomer was obtained under the following
conditions: the combination 50-60 oC/ 6 minutes provided 53 in 28% yield whereas 20-85 oC/ 30
min generated 49 in 41%. Both 49 and 53 underwent Pd-catalyzed couplings with phenyl- or
styrltributylstannane giving mono-bromobutenolides with good stereo- and regeiocontrol. The
mono-bromobutenolides were then either reduced with Zn or was subjected to a second Stille
coupling to produce bromine-free γ-alkylidenebutenolides as single stereoisomers 51, 52, 55, 56.
In 2005, Sorg and co-worker had further explored the above methods and successfully
synthesized the anti-biotic lissoclinolide 59 in 66% yield.21 This synthesis of lissoclinolide is the
shortest reported to date, comprising of just five steps from levulinic acid and is the only one
accomplished without using protecting groups. By comparison, Negishi’s synthesis of
lissoclinolide required nine steps22, Rossi’s eight steps23, and Görth’s earlier synthesis from their
laboratory six steps24. As selective and accessible as it was, the method developed by Sorg and
co-workers often achieved poor yields early in the process. Preparation of the starting gem dibromoolefin and 1,3-dibromo’diene’ resulted in yields only ranging from 28-41%, thus using
this method would achieve highly selective γ-alkylidenebutenolide but in poor yield.21
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Scheme 2-5 Pd-catalyzed cross-coupling to achieve γ-alkylidenebutenolides

Scheme 2-6 Total Synthesis of lissoclinolide

2.4 Lactonization Reactions of Alk-4-ynoic and Alk-4-enoic Acids
In 2002, Anastasia and co-workers reported that the preparation of (Z)-5-organoyl-2-en4-ynoic acids by the Pd-catalyzed alkynylzinc-β-haloacrylic acid coupling followed by Ag2CO3
catalyzed lactonization provided a far superior two-step method for selective synthesis of (Z)-5alkylidenefuran-2(5H)-ones 62, compared to the one-pot alkyne-alkene coupling-lactonization
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tandem process run under Sonogashira coupling conditions (Table 2-1).25 Two of the problems
faced with the one-pot Pd-catalyzed cross-coupling-lactonization tandem process, alkyne
dimerization and Michael-type addition reactions were not observed in the two-step process
(Scheme 2-7,8) .26,27
Table 2-1 Comparison of Ag-catalyzed lactonization of (Z)-2-en-4-ynoic acids with Pdcatalyzed alkyne-alkene cross-coupling lactonization tandem process

yield of 61 + 62 (%)
procedurea

61 : 62

based on 1

based on
alkyne

1A

A

4 : 96

96

90

1B

B

34 : 66

b

77

2A

A

5 : 95

99

93

2B

B

20 : 80

b

75

3A

A

3 : 97

95

88

3B

B

20 : 80

b

65

4A

A

2 : 98

95

86

4B

B

3 : 97

b

76

5A

A

2 : 98

94

88

5B

B

c

b

46

entry

alkyne
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Scheme 2-7 One-pot Pd-catalyzed cross-coupling-lactonization tandem process

Scheme 2-8 Alkyne Dimerization Mechanism

Another lactonization reaction towards the synthesis of γ-alkylidene butenolides was
demonstrated by Rousset and co-workers back in 2000.28 Their method involved the
halolactonization of conjugated dienoic acids followed by DBU-promoted elimination to
selectively yield alkylidene butenolides (Scheme 2-9). The dienoic acids 63 were prepared via
Stille cross-coupling between vinyl tin reagents and (Z)-3-iodoalk-2-enoic acids. They then
focused on formation of the exocyclic double bond via base-mediated anti elimination. After
testing a variety of different bases (TEA and DBN), they found that the most efficient base for
the elimination reaction to occur was DBU in dichloromethane. Their method of elimination was
selective for the (E)-isomer 65, contrasting the selectivity for the (Z)-stereoisomer 66 from other
approaches (Scheme 2-9).28 This methodology was then applied to the synthesis of analogues of
retinoic acid containing the alkylidene butenolide moiety, achieving the desired product such as
butenolide 69 in 65% yield (Scheme 2-10).28
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Scheme 2-9 Synthesis of γ-alkylidenebutenolides via an alk-4-enoic acid

Scheme 2-10 Synthesis of yne analogues of retinoic acid containing the γ-alkylidene
butenolide moiety

2.5 Vinylogous Aldol Reactions
A more recent synthesis of γ-alkylidene butenolides was reported starting from
commercially available 6-aminopenicillanic acid.29 Yu and co-workers had previously identified
that γ-alkylidene butenolides based derivatives showed moderate to excellent biological activities
and could also regulate the intercellular Na+ concentration.30 As part of their ongoing efforts to
identify new biological agents, they discovered that the vinylogous aldol reaction between
different aldehydes or ketones with 70afforded a series of novel γ-alkylidene butenolides 71
(Scheme 2-11). 70 was prepared through the base catalyzed intramolecular cascade sequence in
one-pot under mild conditions. The cascade sequence involved three reactions: (a) substitution
reaction of the chloride with hydroxide anion; (b) the intramolecular transesterification; (c) base
promoted isomerization of double bond.29 The vinylogous aldol reaction of different aldehydes
or ketones with 70 produced the γ-alkylidene butenolides 71 in 53-86% yields with differing
ratios of Z- or E-isomer depending on the R1 and R2 groups.29
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Scheme 2-11 Synthesis of γ-alkylidenebutenolides via vinylogous aldol reaction

It is noteworthy that of the syntheses mentioned, none have been a metathesis-based approach
towards synthesizing γ-alkylidene butenolides.
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Chapter 3. Synthesis of γ-Alkylidene Butenolides
Our unique metathesis-based approach has led us towards investigating the scope of our
method. As mentioned previously in Chapter 1, in an effort to access cis-alkene containing
polyenes we set out to investigate ring-closing metathesis reactions of acyloxysulfones of type
20. During the course of investigating elimination reactions of acyloxysulfone RCM product of
type 22, we discovered that treatment with triethylamine resulted in its quantitative conversion
into the γ-alkylidene butenolide of type 28. Initially we were concerned, however, that this
reaction might be limited only to substrates of type 22a with elimination favored due to
formation of fully conjugated butenolides of type 28a.
3.1 Synthesis of Acyloxysulfones Derivatives
In an effort to explore the scope of γ-alkylidene butenolide synthesis via elimination of
acyloxysulfone RCM products, we first synthesized a variety of acyloxysulfones following the
general scheme shown in Table 3-1. Initially we had performed a two-step addition/acylation
reaction with (ethylsulfonyl)benzene using crotonaldehyde and acryloyl chloride, achieving
acyloxysulfone 20b in 91% yield (Table 3-1). To simplify the two-step process the addition/
acylation reactions could be combined into a one-step process, no longer having to isolate the
intermediate hydroxysulfone (Table 3-1). After synthesizing a range of acyloxysulfones, we
found that in general, the one-step synthesis was preferred and so the two-step was not
performed if high yields were achieved.
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Table 3-1 Synthesis of Acyloxysulfone RCM Substrates

Compound
20a
20b
20c
20d
20e
20f
20g

R
Ph
Me
i-Pr
(CH2)2Ph
n-BuLi
CH=CHPh
CH=CH2

Two-step yield One-step yield
(%)
(%)

X
H
Me
Me
Me
Me
Me
H

64
91
74
64
ND
ND
ND

65
79
83
92
98
91
78

3.2 Ring-closing Metathesis of Acyloxysulfones
Our initial effort towards accessing the cis-alkene involved a ring-closing metathesis
(RCM) reaction. RCM is a widely used olefin metathesis reaction in organic chemistry for the
synthesis of various unsaturated rings; it involves an intramolecular metathesis of two alkenes.
Like many of the other olefin metathesis, both E- or Z- isomers may form. Many factors
influence the stereoselectivity of RCM including: (1) catalyst, (2) ring strain, and (3) starting
diene as previously discussed in chapter one. Although E- isomers tend to be favored
thermodynamically, in smaller rings, the Z- isomers predominate as the more stable product due
to ring-strain minimization.11 To incorporate the cis- alkene in our polyene systems, we thus
decided to do an RCM on the acyloxysulfones to form either a 5- or 6- membered rings. As
stated previously, we were unsuccessful in forming the 6- membered ring and decided to focus
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solely on the 5- membered RCM. The RCM reaction of compounds 20a-g proved somewhat
challenging with similar reactivity observed for both the acrolein-derived compound 20a and the
crotonaldehyde-derived compounds 20b-g. After going through a variety of conditions to
optimize the reaction, we found that the yields were best when the catalyst was loaded in three
separate batches in 6 h increments. With these conditions, we were able to subject
acyloxysulfones 20a-g to the RCM and achieve yields ranging from 51-76% (Scheme 3-1).
Scheme 3-1 Ring-closing metathesis reactions of acyloxysulfones

3.3 Elimination of Ring-closing Metathesis
Our initial proposal was to do a subsequent reductive elimination to the RCM product to
attain the second alkene that had been masked by formation of the acyloxysulfone. Referring
back to chapter one, because elimination of acyloxysulfones favors trans- alkenes, we expected
reductive elimination of the RCM product would give us the anticipated cis-, trans- polyene.
With multiple failed attempts to reductively eliminate the RCM product using typical Julia
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olefination reagents (SmI2, Na/Hg) we set out to try a sequential elimination. The sequential
elimination would proceed first with an elimination of the acyl-group, followed by a reductive
cleavage of the resulting vinyl sulfone. Initially we had tried DBU as outlined by a previous
group7; unsuccessful we moved on to TEA and came across the unexpected synthesis of γalkylidene butenolide 28a.
The unexpected synthesis of compound 28a led us to the focus of our research; exploring
the scope of γ-alkylidene butenolide synthesis by elimination of RCM acyloxysulfones. Our
initial thought was that proton Hb would be more acidic than Ha, resulting in the vinyl sulfone
which could then be followed by a reductive cleavage to achieve the originally desired cis-,
trans-polyene. Unanticipated, Ha was more acidic in the case of benzyl phenyl sulfone leading to
the synthesis of compound 28a in high yield.

Figure 3-1 Expected product when elimination with TEA
We were concerned that this acyloxysulfone RCM/elimination approach would be limited to
benzyl sulfones due to the resulting butenolide being fully conjugated. To explore the scope of
this reaction, (ethylsulfonyl)benzene was then subjected through the entire sequence, and to our
delight the corresponding non-conjugated γ-alkylidene butenolide 28b was formed in excellent
yield (Scheme 3-2). Excited that the elimination worked so clean and well, we synthesized four
more γ-alkylidene butenolides with yields 95% or greater (Scheme 3-2). In addition to the ease
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of the reaction itself (TEA, DCM, and room temperature), often TEA could simply be pumped
off needing no further purification to obtain pure product.
Scheme 3-2 Scope of γ-alkylidene butenolide synthesis

With seven γ-alkylidene butenolides in hand, we wanted to better understand the mechanism of
the elimination itself. At first glance, it seems like a simple E2 elimination takes place (Scheme
3-3), however; this would suggest that the ratio of diastereomers of the product should be
identical to that of the starting material, which is not the case (Scheme 3-1,2).
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Scheme 3-3 E2 reaction mechanism

Throughout the entire sequence up to the RCM product, the ratio of diastereomers consistently
remains about 1:1 (Scheme 3-1), where as you can see in Scheme 3-2, it is clear that the ratio is
no longer 1:1, instead favoring the Z- diastereomer.
3.4 Mechanistic Study
The change in ratio of diastereomers towards favoring the Z- diastereomer was suggestive
of an E1cb mechanism. As seen in Scheme 3-4 the steric hindrance of the β- substituent would
aid in the epimerization of the anti- configuration towards the γ-alkylidene butenolide with Zconfiguration thus making it the major diastereomer.
Scheme 3-4 E1cb reaction mechanism
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We attempted to better understand the elimination process by investigating an acyclic
equivalent compound as detailed in Scheme 3-5. Even after prolonged reaction times (72 h), no
apparent elimination was detected upon treatment with TEA. The failure of the acyclic
compound 72 to react with TEA suggests that it is less acidic than its alternative cyclic
compounds 23a-g. This reactivity trend has been recognized in other cases. A prime example is
the comparison of acidity between Meldrum’s acid (pka = 7.32) and dimethyl malonate (pka =
15.78)31 with the difference in acidity explained by dipole minimization.32 In our case, the
propensity of compounds 23a-g toward elimination and failure of 72 might best be explained by
considering the aromatic nature, and thus increased stability and ease of formation, of the
conjugate base for each cyclic compound. Further efforts will be made to validate this
rationalization; for now, the elimination mechanism is best explained by occurring via E1cb and
is apparently dependent on the increased acidity afforded to the cyclic RCM products.
Scheme 3-5 Comparison of cyclic vs. acyclic acyloxysulfone eliminations with TEA

3.5 Investigating Limitations
We found that elimination of RCM acyloxysulfone products could be applied to a variety
of di- substituted RCM products to achieve the desired γ-alkylidene butenolides; however, we
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found that many γ-alkylidene butenolides are tri- or even tetra- substituted. To access these
compounds, we first began by synthesizing tri- substituted γ-alkylidene butenolides containing a
methyl group at either the C2 or C3 position (Scheme 3-6). Using the same method as the disubstituted, both tri- substituted γ-alkylidene butenolides were synthesized in good yields (79100%).
Scheme 3-6 Synthesis of tri- substituted γ-alkylidene butenolide

Synthesizing a tetra-substituted γ-alkylidene butenolide proved to be challenging. The
starting acyloxysulfone 74 was prepared by addition with methacrolein (84% yield) followed by
acylation with methyacryloyl chloride (76% yield). Our first attempt at forming the tetrasubstituted RCM product using our previous conditions with Ru-1 catalyst failed and resulted in
recovery of starting material. Based on a previous study by Stewart and co-workers, they showed
that a higher conversion for the tetra-substituted RCM of diethyl dimethallylmalonate was
achieved with Ru-4 catalyst.33 In a second attempt to reach the tetra-substituted RCM product
we tried the Ru-4 catalyst at 60, 80, and 110 °C but once again only starting material was
detected.
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Scheme 3-7 Synthesis of tetra- substituted γ-alkylidene butenolide

Thus far our metathesis based approach towards γ-alkylidene butenolides seemed limited
to only di- and tri- substitutuded γ-alkylidene butenolides. Understanding the limitation to trisubstituted substrates, we wanted to investigate what groups could be tolerated at those positions.
We first set out on probing whether a halogen could be at the C2 position. Compound 19a was
acylated with 2-bromoacryloyl chloride 76 to attain β-acyloxysulfone 77. Unfortunately, the
RCM reaction with Ru-1 did not achieve the desired product 78 and only starting material was
detected, thus adding another limitation to our approach. Although this is perhaps not surprising
given the electron-deficient nature of the bromosubstituted alkene in 77.
Scheme 3-8 Attempted bromo-butenolide RCM

Failing to tolerate a halogen group, we then set out to investigate whether we could
include a phenyl group at the C3 position. We first had to synthesize the aldehyde itself in order
for us to access the phenyl group in the correct position. Alcohol 80 was synthesized via a
Grignard reaction with 79. After several attempts at different oxidation reactions, DMP proved to
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be the most successful in synthesizing aldehyde 81. A two-step addition/acylation was then
executed with 2-phenylacrylaldehyde 81 and acyrloyl chloride and benzyl phenylsulfone to
achieve the desired β-acyloxysulfone 83. We then attempted to do an RCM to get the phenyl trisubstituted ring; however even after several attempts with Ru-1 at 80°C and 110°C, no product
was identified. In one last attempt to close the ring with Ru-1, titanium isopropoxide was used as
an additive to prevent any potential catalyst poisoning that could take place. The reaction was
placed in DCM and refluxed for 12 h, even then, no product was detected. Recalling the study
done by Stewart, we tried using the Ru-4 catalyst to close the ring. Once again, the phenyl trisubstituted ring failed to close. From all of the RCM reactions (Table 3-2), only starting material
was detected. This is surprising given the report from Chaven describing successful RCMs of
this type.39 This is also unfortunate because it would have given us access to the rubrolide natural
products (Figure 3-2).
Scheme 3-9 Synthesis of 2-phenylacrylaldehydeI-II
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Scheme 3-10 Attempted phenyl-substituted butenolide RCM

Table 3-2 Conditions for RCM of acyloxysulfone 83

Catalyst

Solvent

Time

Temp.

Ru-1

Toluene

24 h

80

Ru-1

Toluene

24 h

110

Ru-1*

DCM

12 h

reflux

Ru-4

Toluene

24 h

80

*titanium isopropoxide was added

Figure 3-2 Natural product rubrolide derivatives
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Chapter 4. Application Towards Naturally Occurring γ-Alkylidene Butenolides
4.1 Attempt at synthesizing Rubrolide via Heck-coupling
Failure to access the Rubrolide core through a tri- phenyl substituted RCM was
disappointing; however, we had already synthesized a majority of the structure (compound 19a).
A second attempt at synthesizing Rubrolide was done via Heck-coupling to 19a. Aware of the
many potential products that could be formed, 19a was still subjected to the Heck reaction
simply due to the abundance of the material at that time. After several different conditions and
reagents, not only did the Heck-coupling reaction fail to form the C-C bond between C3 of 19a
and the bromide compound to make 85, all the starting material was recovered.
Table 4-1 Synthesis of Rubrolide via Heck-coupling

R

Catalyst

Ligand

Base

H

Pd(Oac)2

PPh3

TEA

H

Pd(dba)2

none

K3PO4

Me

Pd(Oac)2

PPh3

TEA

Me

Pd(dba)2

none

K3PO4
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4.2 Spirobutenolide Synthesis
While researching natural products that contained the γ-alkylidene butenolide moiety, we
came across a paper by Engstrom and co-workers who had synthesized pyrenolide D 87 in a twostep, one-pot transformation using γ-alkylidene butenolide 86.34 The reaction involved an initial
hydrolysis of the γ-alkylidene butenolide with LiOH, followed by acid-mediated TBSdeprotection with HF and spiroketalization to form 87. Excited that we could potentially
synthesize a variety of γ-alkylidene butenolides and spirocyclize them meant that we could
access several spirobutenolide natural products (Figure 4-1).
Scheme 4-1 Synthesis of pyrenolide D in a two-step, one-pot transformation using γalkylidene butenolide

Figure 4-1 Natural product spirobutenolides
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Often times model compounds of natural products are first synthesized first to show
proof-of-principle before attempting the actual product (Figure 4-2). For pyrenolide D 87, we
imagined synthesizing a 5,5-spirobutenolide starting from a TBS-protected γ-alkylidene
butenolide 96. To get to the TBS-protected sulfone, we had to first synthesize the TBS-protected
alcohol 89 (Scheme 4-2). A mono TBS-protection on propanediol 88 was followed by an
iodination and sulfone displacement to achieve the desired sulfone 91. Once the TBS-protected
sulfone was purified, we could then apply our metathesis approach to get the γ-alkylidene
butenolide. We began with an addition of the TBS-protected sulfone to crotonaldehyde followed
by acylation with acryloyl chloride to get 92 in 46% yield. A ring-closing metathesis on βacyloxysulfone 92 was then achieved with Ru-1 in 74% yield. The final step in attaining γalkylidene butenolide 96 was completed by reductive elimination of 95 with TEA. Once the
TBS-protected γ-alkylidene butenolide 96 was synthesized, spirocyclization of the compound
was attempted according to the procedure outlined in the paper by Engstrom and co-workers.34
On the very first attempt, formation of the γ- 5,5-spirobutenolide 97 was successful (the low
yield of 97 was due to loss of material while transferring).

Figure 4-2 Retrosynthesis of 5,5-spirobutenolide
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Scheme 4-2 Synthesis of TBS-protected sulfone

Scheme 4-3 Synthesis of TBS-protected γ-alkylidene butenolide

Scheme 4-4 Synthesis of 5,5-spirobutenolide

Wanting to better understand the mechanism in which the γ-alkylidene butenolide
spirocyclization, we found a paper in which they described the cyclization as a “5-endo-trig ring
closure process” (Scheme 4-5).35 This paper suggests that spirocyclization can occur in the
absence of LiOH and that HF-pyr will deprotect the TBS-protected alcohol to allow for a 5endo-trig cyclization to occur (Scheme 4-6). According to Baldwins’ Rules, deprotection
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followed by a 5-endo-trig process is unlikely and highly unfavorable.36 Instead, the more likely
route in which the γ-alkylidene butenolide spirocyclizes is via the 5-exo-trig process (Scheme 47). Nonetheless, from their results HF-pyridine should be sufficient alone to promote
spirocylization according to this report.
Scheme 4-5 Example of spirocyclization process by Popsavin35

Scheme 4-6 5-endo-trig ring closure

Scheme 4-7 5-exo-trig ring closure
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Yang and co-workers recently reported the isolation of a spirocyclic butenolide natural
product abiespiroside A (Figure 4-3), 37 which they described as possessing “diverse forms of
bioactivity such as anti-inflammatory, antitumor, antibacterial, and insecticide activity”.38
Wanting to first investigate the 6/6/5 ring system, we set out to synthesize a model 6,5spirobutenolide (Scheme 4-8,9). Similar to the 5,5-spirobutenolide, we began with a mono TBS
protection on cis-butenediol 101. This was followed by a hydrogenation, although the
hydrogenation gave a mixture of the alcohol 103 and aldehyde 104. The aldehyde was easily
converted to the desired alcohol 103 by reduction with NaBH4. Compound 103 was then
subjected to an iodination followed by a sulfone displacement producing the desired starting
sulfone 105. We were then able to take sulfone 105 through our RCM/elimination sequence to
ultimately get γ-alkylidene butenolide 109. Wanting to confirm if Popsavin35 was in fact correct,
an attempt to spirocyclize 109 with just HF-pyr was executed (Scheme 4-10). Unfortunately, in
the presence of just HF-pyr 109 did not spirocyclize but had instead completely decomposed. In
a second attempt to spirocyclize 109, we followed the conditions previously outlined by
Engstrom34 involving first LiOH followed by HF and was successful in synthesizing 6,5spirobutenolide 110 in 77% yield. This result now sets the stage for a completion of the total
synthesis of abiespiroside A.

Figure 4-3 Structure of abiespiroside A
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Scheme 4-8 Synthesis of alcohol 103

Scheme 4-9 Synthesis of TBS-protected γ-alkylidene butenolide 109

Scheme 4-10 Synthesis of 6,6-spirobutenolide
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Chapter 5. Conclusion
5.1 Discovery and Development of a Metathesis-Based Approach Synthesis of γ-Alkylidene
Butenolides
In the midst of investigating an olefin metathesis based approach towards accessing cistrans- polyene subunits, we unexpectedly synthesized a γ-alkylidene butenolide 28a. γAlkylidene butenolides are an interesting class of compounds due to their range of biological
properties which includes antitumor, anti-inflammatory, antibacterial, and cholesterol
biosynthesis inhibition.12-15 Utilizing the Julia reaction, a variety of acyloxysulfones were
successfully synthesized using either a two-step or a one-pot addition-acylation method. Ringclosing metathesis reactions of the acyloxysulfones allowed for ring closure of di- and trisubstituted rings with limitations thus far to methyl groups. A mild triethylamine-mediated
sulfone elimination produced the corresponding γ-alkylidene butenolides. After optimization,
yields for the sequence were overall high (69-100%), giving γ-alkylidene butenolide products
with up to 15:1 selectivity for the Z-isomer. The mechanism for elimination appears to be E1cb
and is apparently dependent on the increased acidity afforded to the cyclic RCM products.
In an attempt to showcase this method in the context of complex γ-alkylidene butenolide
natural product synthesis, we came across a paper by Engstrom34 that had described using a γalkylidene butenolide as a precursor for synthesizing Pyrenolide D, a natural product
spirobutenolide. Using our metathesis-based approach, we were able to synthesize a γ-alkylidene
butenolide that was able to spirocyclize to a 5,5-spirobutenolide as a model compound for
Pyrenolide D. The same approach was successfully applied to the successful synthesis of the
abiespiroside A 6,5-spirobutenolide.
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5.2 Future Work
In conclusion, the metathesis-based synthesis of γ-alkylidene butenolides has allowed for
the synthesis of a 6,5-spirobutenolide which was a model compound for the natural
spirobutenolide Abiespiroside A.37 Due to the complex stereochemistry of Abiespiroside A, our
next goal is to synthesize a more intricate representation as shown in Figure 5-1. Access to this
model would then allow us to further develop a method for the total synthesis of Abiespiroside
A.

Figure 5-1 Model compound for Abiespiroside A
As we work towards a total synthesis of a natural spirobutenolide, we would also like to
overcome the challenges with our metathesis-based approach for synthesizing γ-alkylidene
butenolide. Thus far our limitations include not having a halogen at the C2 position, a phenyl
group at the C3 position, and tetra- substituted γ-alkylidene butenolides (Figure 5-2).
Overcoming these challenges would allow access to many more complex γ-alkylidene butenolide
natural product synthesis.

Figure 5-2 Limitations to the metathesis-based synthesis of γ-alkylidene butenolides
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Chapter 6. Experimentals

All reactions were carried out under N2 in flame-dried glassware. The solvents used were
dried by passing the solvent through a column of activated alumina under nitrogen immediately
prior to use. All other reagents were purchased and used as received. All TLC analysis used 0.25
mm silica layer fluorescence UV254 plates. Flash chromatography: SilaCycle silica gel P60
(230-400 mesh). IR: Nicolet iS10 spectrometer, wavenumbers (ṽ) in cm-1. NMR: Spectra were
recorded on a Varian Mercury 300, or Inova 500 spectrometer in the solvents indicated; chemical
shifts (δ) are given in ppm, coupling constants (J) in Hz. The solvent signals were used as
references (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.26 ppm). MS(ESI): Waters
LCT Premier mass spectrometer.

(isobutylsulfonyl)benzene. Benzenesulfinic acid sodium salt (4.00 g, 24.37 mmol, 2.0 equiv.) was
added to a flask containing DMSO (8.53 mL). 1-Bromo-2-methylpropane (1.31 mL, 12.18 mmol,
1.0 equiv.) was then added and the mixture was heated to 100°C and stirred for 15 h. The reaction
was cooled to room temperature, quenched with water (25 mL) and extracted with DCM (2 x 20
mL). The combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo.
Purification by flash column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave
(isobutylsulfonyl)benzene (4.23 g, 89%) as an oil.
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IR (ATR): 1302, 1143, 1085, 595 cm-1.1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 7.5 Hz, 2H),
7.65 (t, J = 7.6 Hz, 1H), 7.57 (t, J = 7.7 Hz, 2H), 2.99 (d, J = 6.5 Hz, 2H), 2.22 (m, 1H), 1.06 (d, J
= 6.8, 6H). 13C NMR (125 MHz, CDCl3) δ 140.2, 133.5, 129.3, 127.8, 64.0, 24.1, 22.7. TOFMS
(ES+): m/z calcd for C15H16O2SNa [M + Na]+: 221.0612; found: 221.0618.

((3-phenylpropyl)sulfonyl)benzene. Benzenesulfinic acid sodium salt (2.80 g, 17.08 mmol, 2.0
equiv.) was added to a flask containing DMSO (8.53 mL). 1-Bromo-3-phenylpropane (1.30 mL,
8.53 mmol, 1.0 equiv.) was then added and the mixture was heaed to 100°C and stirred for 15 h.
The reaction was cooled to room temperature, quenched with water (25 mL) and extracted with
DCM (2 x 20 mL). The combined organic extracts were dried over MgSO 4, filtered, and
concentrated in vacuo.

Purification by recrystallization with ethanol afforded ((3-

phenylpropyl)sulfonyl)benzene (3.55 g, 80%) as a white solid.

IR (ATR): 1452, 1295, 1187, 1145, 1126, 580, 529 cm-1. 1H NMR (500 MHz, CDCl3) δ 7.89 (d, J
= 8.0 Hz, 2H), 7.66 (m, 1H), 7.56 (t, J = 7.9, 2H), 7.27 (t, J = 7.3 Hz, 2H), 7.2 (t, J = 7.4 Hz, 1H),
7.10 (d, J = 6.9 Hz, 2H), 3.08 (m, 2H), 2.70 (t, J = 7.5 Hz, 2H), 2.05 (m, 2H). 13C NMR (125 MHz,
CDCl3) δ 139.8, 139.2, 133.6, 129.3, 128.6, 128.4, 128.0, 126.4, 55.4, 34.1, 24.2. TOFMS (ES+):
m/z calcd for C15H16O2SNa [M + Na]+: 283.0769; found: 283.0764.
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(E)-((3-phenylallyl)sulfonyl)benzene. To a solution of 3-bromoprop-1-ene (1.40 g, 11.6 mmol)
in DMSO (11.57 ml) at 100 oC was added benzenesulfinic acid sodium salt (3.80 g, 23.1 mmol)
and the mixture was stirred for 15 h. The reaction was quenched with H2O (35 ml) and extracted
with DCM (2 x 30 ml). The combined organic extracts were dried over MgSO4, filtered, and
concentrated in vacuo.

Purification by recrystallization in ethanol afforded (E)-((3-

phenylallyl)sulfonyl)benzene (2.39 g, 91%).

IR (ATR) 3012, 2974, 2905, 2871, 1292, 1054 cm-1. 1H NMR (500MHz, CDCl3): δ 7.89 (dd, J =
8.2, 1.1 Hz, 2H) 7.64 (m, 1H), 7.54 (m, 2H), 7.33 – 7.21 (m, 5H), 6.37 (d, J = 15.8 Hz, 1H), 6.11
(td, J = 15.3, 7.8 Hz, 1H), 3.96 (dd, J = 7.6, 1.1Hz, 2H,).

C NMR (75 MHz, CDCl3): δ 139.2,

13

138.4, 135.7, 133.8, 129.1 (2C), 128.9 (2C), 128.8 (2C), 126.6 (2C), 115.1, 60.5. TOFMS (ES+):
m/z calcd for C15H14O2SNa [M + Na]+: 281.0612; found: 281.0611.

(allylsulfonyl)benzene40. To a solution of cinnamyl bromide (2.00 g, 10.15 mmol) in DMSO (10.2
ml) at 100 oC was added benzenesulfinic acid sodium salt (3.33 g, 20.3 mmol) and the mixture
was stirred for 15 h. The reaction was quenched with H2O (35 ml) and extracted with DCM (2 x
30 ml). The combined organic extracts were dried over MgSO4, filtered, and concentrated in
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vacuo. Purification by flash column chromatography on silica (1:1 hexanes:ethyl acetate) gave
(allylsulfonyl)benzene (1.6 g, 76%) as an oil.

1-phenyl-1-(phenylsulfonyl)but-3-en-2-yl acrylate (20a). Two-step method: To a solution of
benzyl phenyl sulfone (300 mg, 1.29 mmol, 1.0 equiv.) in THF (6.5 mL) at -78 °C was added nBuLi (1.6 M, 2.42 mL, 3.87 mmol, 3.0 equiv.) and the mixture was stirred for 1 h before adding
acrolein (0.43 mL, 6.45 mmol, 5.0 equiv.) and stirring for 2 h. The reaction was quenched with
water (20 mL) and extracted with MTBE (2 x 20 mL). The combined organic extracts were dried
over MgSO4, filtered, and concentrated in vacuo. Purification by flash column chromatography on
silica (4:1 to 1:1 hexanes:ethyl acetate) gave the corresponding hydroxysulfone (0.24 g, 64%) as
an inseparable mixture of diastereomers.

Spectral data for the mixture of diastereomers: IR (ATR): 3538, 3475, 1494, 1346, 1142, 688 cm. H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 7.7 Hz, 2H), 7.56-7.49 (m, 4H), 7.39-7.32 (m, 6H),

1 1

7.30-7.17 (m, 6H), 7.00 (d, J = 7.4 Hz, 2H), 5.69 (m, 1H), 5.54 (m, 1H), 5.35 (d, J = 15.6 Hz, 1H),
5.31 (d, J = 15.0 Hz, 1H), 5.26 (d, J = 6.4 Hz, 1H),5.24 (d, J = 6.2 Hz, 1H), 5.12 (d, J = 10.5, 1H),
5.05 (d, J = 10.4 Hz, 1H), 4.18 (s, 1H), 4.16 (d, J = 9.4 Hz, 1H), 4.09 (d, J = 2.7 Hz, 1H), 3.19 (s,
1H). ).

13

C NMR (125 MHz, CDCl3) δ 137.7, 137.3, 136.2, 135.7, 133.9, 133.7, 131.3, 130.7,
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130.4, 129.4, 128.9, 128.8, 128.7, 128.7, 128.5, 128.4, 128.3, 117.9, 117.6, 76.5, 74.9, 71.1, 70.7.
TOFMS (ES+): m/z calcd for C16H16O3SNa [M + Na]+: 311.0718; found: 311.0707.

To a solution of 1-phenyl-1-(phenylsulfonyl)but-3-en-2-ol (0.24 g, 0.82 mmol) in DCM (4.0 mL)
at 0°C was added triethylamine (0.29 mL, 2.05 mmol, 2.5 equiv.) followed by acryloyl chloride
(0.13 mL, 1.64 mmol, 2.0 equiv.) and the mixture was allowed to slowly warm to room temperature
over 15 h. The reaction was quenched with aq. sodium bicarbonate (20 mL) and extracted with
DCM (2 x 20 mL). The combined organic extracts were dried over MgSO4, filtered, and
concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1
hexanes:ethyl acetate) gave compound 20a (82 mg, 100%) as an inseparable mixture of
diastereomers.

One-step method: To a solution of benzyl phenyl sulfone (300 mg, 1.29 mmol, 1.0 equiv.) in THF
(6.40 mL) at -78°C was added n-BuLi (1.6M, 2.42 mL, 3.87 mmol, 3.0 equiv.) and the mixture
was stirred for 1 h before adding acrolein (0.43 mL, 6.45 mmol, 5.0 equiv.) and stirring for 2 h.
The mixture was warmed to 0°C followed by the dropwise addition of acryloyl chloride (0.52 mL,
6.45 mmol, 5.0 equiv.) and the resulting mixture was allowed to slowly warm to room temperature
over 12 h. The reaction was quenched with aq. NH4Cl (20 mL) and extracted with MTBE (2 x 20
mL). The combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo.
Purification by flash column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave
compound 20a (0.29 g, 65%) as an inseparable mixture of diastereomers.
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Spectral data for the mixture of diastereomers: IR (ATR): 1727, 1405, 1308, 1293, 1260, 1175,
1145 cm-1. 1H NMR (500 MHz, CDCl3) δ 7.64 (d, J = 7.5 Hz, 2H), 7.55-7.50 (m, 4H), 7.40-7.35
(m, 4H), 7.33-7.22 (m, 10H), 6.38 (dd, J = 17.0, 10.0 Hz, 2H), 6.34 (m, 1H), 6.27 (m, 1H), 6.07
(dd, J = 17.4, 10.5 Hz, 1H), 5.94 (dd, J = 17.4, 10.5 Hz, 1H), 5.85 (dd, J = 10.5, 1.3 Hz, 1H), 5.81
(dd, J = 10.5, 1.3 Hz, 1H), 5.75-5.60 (m, 2H), 5.33 (dd, J = 17.1, 1.1 Hz, 1H), 5.24 (dd, J = 17.1,
1.1 Hz, 1H), 5.21 (dd, J = 10.4, 1.0 Hz, 1H), 5.12 (dd, J = 10.5, 1.0 Hz, 1H). 13C NMR (125 MHz,
CDCl3) δ 164.4, 164.3, 139.2, 138.0, 133.7, 133.4, 132.9, 132.6, 131.8, 131.7, 131.2, 130.7, 130.0,
129.6, 129.2, 129.1, 128.8, 128.7, 128.6, 128.3, 127.9, 127.8, 119.7, 119.6, 74.0, 73.4, 72.5, 71.5.
TOFMS (ES+): m/z calcd for C19H18O4SNa [M + Na]+: 365.0823; found: 365.0808.

(E)-2-(phenylsulfonyl)hex-4-en-3-yl acrylate (20b). To a solution of ethyl phenyl sulfone (1.00
g, 5.87 mmol, 1.0 equiv.) in THF ( 29.0 mL), at -78°C was added n-BuLi (1.6M, 4.40 mL, 7.05
mmol, 1.2 equiv.) and the mixture was stirred for 1 h before adding crotonaldehyde (0.96 mL,
11.74 mmol, 2.0 equiv.) and stirring for 2 h. The reaction was then quenched with water (50 mL)
and extracted with MTBE (2 x 25 mL). The combined organic extracts were dried over MgSO 4,
filtered, and concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to
1:1 hexanes:ethyl acetate) gave the corresponding hydroxysulfone (1.21 g, 91%) as a separable
mixture of diastereomers (α and β)
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Spectral data for isomer α: 1H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 7.5 Hz, 2H), 7.68 (t, J =
7.5 Hz, 1H), 7.58 (t, J = 7.7 Hz, 2H), 5.75 (m, 1H), 5.38 (dd, J = 15.3, 4.4 Hz, 1H), 4.76 (d, J =
5.3 Hz, 1H), 3.08 (qd, J = 7.1, 1.1 Hz, 1H), 2.97 (s, 1H), 1.68 (d, J = 6.5 Hz, 3H), 1.30 (d, J = 7.2
Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 137.6, 134.0, 129.3, 128.9, 128.8, 128.7, 68.8, 64.0,
17.7, 6.8

Spectral data for isomer β: IR (ATR): 1447, 1286, 1140, 1084, 730 cm-1. 1H NMR (500 MHz,
CDCl3) δ 7.90 (d, J = 7.65 Hz, 2H), 7.68 (t, J = 7.4 Hz, 1H), 7.58 (t, J = 7.6 Hz, 2H), 5.74 (m,
1H), 5.38 (qd, J = 7.7, 1.2 Hz, 1H), 4.38 (t, J = 8.0 Hz, 1H), 3.85 (s, 1H), 3.18 (m, 1H), 1.69 (d, J
= 6.6 Hz, 3H), 1.10 (d, J = 7.1 Hz, 3H).13C NMR (125 MHz, CDCl3) δ 137.2, 134.0, 130.7,
129.2, 129.0, 129.9, 72.1, 64.8, 17.7, 12.2. TOFMS (ES+): m/z calcd for C11H14O3SNa [M +
Na]+: 263.0718; found: 263.0718.

To a mixture of (E)-2-(phenylsulfonyl)hex-4-en-3-ol isomers α and β (300 mg, 1.25 mmol, 1.0
equiv.) in DCM (4.1 mL) at 0°C was added triethylamine (0.44 mL, 3.12 mmol, 2.5 equiv.) and
acryloyl chloride (0.15 mL, 1.87 mmol, 1.5 equiv.) and the mixture was allowed to slowly warm
to room temperature over 15 h. The reaction was quenched with aq. sodium bicarbonate (20 mL)
and extracted with DCM (2 x 20 mL). The combined organic extracts were dried over MgSO4,
filtered, and concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to
1:1 hexanes:ethyl acetate) gave compound 20b (0.21 g, 59%) as an inseparable mixture of
diastereomers.
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One-step method: To a solution of ethyl phenyl sulfone (500 mg, 2.94 mmol, 1.0 equiv.) in THF
(14.7 mL) at -78°C was added n-BuLi (1.6M, 2.20 mL, 3.52 mmol, 1.2 equiv.) and the mixture
was stirred for 1 h before adding crotonaldehyde (0.48 mL, 5.88 mmol, 2.0 equiv.) and stirring for
10 min. The mixture was warmed to 0°C and then acryloyl chloride (0.49 mL, 5.88 mmol, 2.0
equiv.) was added and the resulting mixture was allowed to slowly warm to room temperature ober
15 h. The reaction was then quenched with aq. NH4Cl (30 mL) and extracted with DCM (2 x 20
mL). The combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo.
Purification by flash column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave
compound 20b (0.64 g, 78%) as an inseparable mixture of diastereomers

Spectral data for the mixture of diastereomers: IR (ATR):1792, 1745, 1149, 797, 765, 740, 719
cm-1. 1H NMR (500 MHz, CDCl3) δ 7.88-7.84 (m, 4H), 7.65-7.61 (m, 2H), 7.56-7.52 (m, 4H),
6.26-6.21 (m, 3H), 5.88-5.71 (m, 6H), 5.63 (t, J = 7.5 Hz, 1H), 5.47-5.36 (m, 2H), 3.51 (dq, J =
8.0, 8.0 Hz, 1H), 3.25 (m, 1H), 1.71 (d, J = 6.5 Hz, 3H), 1.68 (d, J = 6.5 Hz, 3H), 1.47-1.45 (m,
3H), 1.37-1.35 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 164.3, 164.3, 138.9, 133.8, 133.7, 132.9,
131.3, 131.0, 129.3, 129.2, 129.1, 129.0, 128.6, 128.5, 128.2, 127.9, 125.6, 124.7, 72.8, 70.8, 63.6,
62.2, 17.8, 17.7, 10.1, 8.4. TOFMS (ES+): m/z calcd for C14H16O4SNa [M + Na]+: 317.0823;
found: 317.0816.
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(E)-6-methyl-5-(phenylsulfonyl)hept-2-en-4-yl acrylate (20c). One-step method: To a solution
of (isobutylsulfonyl)benzene (500 mg, 2.52 mmol, 1.0 equiv.) in THF (12.6 mL) at -78 °C was
added n-BuLi (1.6M, 1.89 mL, 3.03 mmol, 1.2 equiv.) and the mixture was stirred for 1 h.
Crotonaldehyde (0.41 mL, 5.04 mmol, 2.0 equiv.) was then added and the reaction was stirred for
10 min then warmed to 0°C for 10 min followed by the addition of acryloyl chloride (0.41 mL,
5.04 mmol, 2.0 equiv.). The mixture was allowed to slowly warm to room temperature over 15 h
before quenching with aq. NH4Cl (20 mL) and extracting with DCM (2 x 15 mL). The combined
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. Purification by flash
column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave compound 20c (0.67 g,
83%) as an inseparable mixture of diastereomers.

Spectral data for the mixture of diastereomers: IR (ATR): 1724, 1447, 1303, 1177, 1143, 619,
608, 591 cm-1. 1H NMR (500 MHz, CDCl3) δ 7.50 (d, J = 7.5 Hz, 4H), 7.63 (dd, J = 9.0, 8.0 Hz, 2
H), 7.53 (dd, J = 8.5, 8.0 Hz, 4H), 7.31-7.18 (m, 6H), 7.16 (d, J = 7.5 Hz, 2H), 7.10 (d, J = 7.0 Hz,
2H), 6.23 (d, J = 17.5 Hz, 2H), 5.88-5.68 (m, 7H), 5.61 (m, 1H), 5.51 (dd, J = 15.0, 7.0 Hz, 1H),
5.27 (dd, J = 15.0, 6.5 Hz, 1H), 3.39 (q, J = 5.5 Hz, 1H), 3.17 (m, 1H), 2.96-2.73 (m, 4H), 2.402.29 (m, 2H), 2.18-2.08 (m, 2H), 1.73 (d, J = 6.5 Hz, 3H), 1.63 (d, J = 6.5 Hz, 3H). 13C NMR (125
MHz, CDCl3) δ 164.4, 164.3, 140.3, 139.5, 133.8, 133.7, 132.5, 131.5, 131.4, 130.8, 129.3, 129.2,
129.0, 128.8, 128.7, 128.7, 128.6, 128.6, 128.5, 128.4, 127.9, 127.8, 126.4, 126.3, 125.7, 124.6,
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72.2, 71.3, 66.6, 65.6, 34.0, 33.2, 26.6, 25.8, 17.9, 17.7. TOFMS (ES+): m/z calcd for C16H20O4SNa
[M + Na]+: 345.1136; found: 345.1125.

(E)-7-phenyl-5-(phenylsulfonyl)hept-2-en-4-yl acrylate (20d). To a solution of ((3phenylpropyl)sulfonyl)benzene (300 mg, 1.15 mmol, 1.0 equiv.) in THF (5.75 mL) at -78 °C was
added n-BuLi (1.6M, 0.86 mL, 1.38 mmol, 1.2 equiv.) and the mixture was stirred for 1 h before
adding crotonaldehyde (0.19 mL, 2.3 mmol, 2.0 equiv.) and stirring for 10 min. The mixture was
warmed to 0°C and then acryloyl chloride (0.19 mL, 2.30 mmol, 2.0 equiv.) and the resulting
mixture was allowed to slowly warm to room temperature over 15 h. The reaction was quenched
with aq. NH4Cl (15 mL) and extracted with DCM (2 x 15 mL). Purification by flash column
chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave compound 20d (407 mg, 92%)
as an inseparable mixture of diastereomers.

Spectral data for the mixture of diastereomers: IR (ATR): 1743, 1497, 1304, 1176, 1144, 728, 690
cm-1. 1H NMR (500 MHz, CDCl3) δ) 7.50 (d, J = 7.5 Hz, 4H), 7.63 (dd, J = 9.0, 8.0 Hz, 2 H), 7.53
(dd, J = 8.5, 8.0 Hz, 4H), 7.31-7.18 (m, 6H), 7.16 (d, J = 7.5 Hz, 2H), 7.10 (d, J = 7.0 Hz, 2H),
6.23 (d, J = 17.5 Hz, 2H), 5.88-5.68 (m, 7H), 5.61 (m, 1H), 5.51 (dd, J = 15.0, 7.0 Hz, 1H), 5.27
(dd, J = 15.0, 6.5 Hz, 1H), 3.39 (q, J = 5.5 Hz, 1H), 3.17 (m, 1H), 2.96-2.73 (m, 4H), 2.40-2.29
(m, 2H), 2.18-2.08 (m, 2H), 1.73 (d, J = 6.5 Hz, 3H), 1.63 (d, J = 6.5 Hz, 3H). 13C NMR (125
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MHz, CDCl3) δ 164.4, 164.3, 140.3, 139.5, 133.8, 133.7, 132.5, 131.5, 131.4, 130.8, 129.3, 129.2,
129.0, 128.8, 128.7, 128.7, 128.6, 128.6, 128.5, 128.4, 127.9, 127.8, 126.4, 126.3, 125.7, 124.6,
72.2, 71.3, 66.6, 65.6, 34.0, 33.2, 26.6, 25.8, 17.9, 17.7. TOFMS (ES+): m/z calcd for C21H22O4SNa
[M + Na]+: 407.1293; found: 407.1292.

(E)-5-((phenylperoxy)thio)non-2-en-4-yl acrylate (20e). To a solution of pentyl phenyl sulfone
(500mg, 2.35 mmol) in THF (11.7 mL) at -78 oC was added n-BuLi (1.6M, 1.8 mL) and the mixture
was stirred for one hour before adding crotonaldehyde (0.387ml, 4.71 mmol) and stirring for 10
min. The mixture was then warmed to 0 oC and acryloyl chloride (0.38 ml, 4.71 mmol) was then
added and the reaction was allowed to warm to room temperature overnight (~15 h). The reaction
was quenched with H2O (30 ml) and extracted with EtOAc (2 x 20 ml). The combined organic
extracts were dried over MgSO4, filtered, and concentrated in vacuo. Purification by flash column
chromatography on silica (10:1 to 4:1 to 1:1 hexanes:ethyl acetate) afforded compound 20e (792
mg, 96%) as a 1:1 inseparable mixture of diastereomers.

Spectral data for the mixture of diastereomers: IR (ATR) 3021, 2957, 2871, 1725, 1144 cm-1. 1H
NMR (500MHz, CDCl3): δ 7.86 - 7.81 (m, 4H), 7.62 -7.56 (m, 2H), 7.53 - 7.48 (m, 4H), 6.22 6.16 (m, 2H), 5.83 - 5.64 (m, 8H), 5.53 - 5.44 (m, 2H), 3.33 (dt, J = 6.6, 5.1 Hz, 1H), 3.16 (ddd, J
= 6.1, 2.4, 2.4 Hz, 1H), 2.04-1.90 (m, 2H), 1.83-1.74 (m, 2H), 1.69-1.65 (m, 6H), 1.83-1.20 (m,
54

8H), 0.88 (t, J = 7.6 Hz, 3H), 0.82 (t, J = 7.4 Hz, 3H).

13

C NMR (75 MHz, CDCl3): δ 164.7, 164.5,

139.9, 139.1, 133.8, 133.7, 132.5, 131.5 (2C), 131.4, 129.3 (4C), 129.1 (2C), 128.8 (2C), 128.1,
128.0, 125.9, 124.9, 72.6, 71.9, 67.1, 68.2, 30.4, 26.6, 24.7, 24.1, 22.7, 22.6, 18.0, 17.9, 13.9, 13.8.
TOFMS (ES+): m/z calcd for C18H24O4SNa [M + Na]+: 359.1293; found: 359.1281.

(1E,5E)-1-phenyl-3-((phenylperoxy)thio)hepta-1,5-dien-4-yl acrylate (20f). To a solution of
(E)-((3-phenylallyl)sulfonyl)benzene (500 mg, 1.95 mmol) in THF (9.7 mL) at -78 oC, was added
n-BuLi (1.6 M, 1.2 ml) and the mixture was stirred for one hour, before adding crotonaldehyde
(0.3 ml, 3.87 mmol) and stirring for 10 min. The mixture was then warmed to 0 oC and acryloyl
chloride (0.3 ml, 3.87 mmol) was then added and the reaction was allowed to warm to room
temperature overnight (~15 h). The reaction was quenched with H2O (30 ml) and extracted with
EtOAc (2 x 20 ml). The combined organic extracts were dried over MgSO4, filtered, and
concentrated in vacuo. Purification by flash column chromatography on silica (10:1 to 4:1 to 1:1
hexanes:ethyl acetate) afforded compound 20f (680 mg, 91%) as a 1.5:1 mixture of diastereomers.

Spectral data for the major diastereomer FT-IR (ATR) 3027, 2945, 1724, 1305, 1259, 1175, 1145
cm-1. 1H NMR (500MHz, CDCl3): δ 7.82 (d, J = 8.2 Hz, 2H) 7.58 (t, J = 7.9 Hz, 1H), 7.47 (t, J =
8.0 Hz , 2H), 7.32 – 7.23 (m, 5H), 6.32 (dd, J = 17.3, 1.4 Hz, 1H), 6.30 (d, J = 15.8 Hz, 1H), 6.005.86 (m, 4H), 5.76 (dd, J = 1.6, 10.5 Hz, 1H), 5.55 (ddd, J = 1.4, 7.5, 9.3, 1H), 4.11 (dd, J = 9.9,
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6.3 Hz, 1H), 1.70 (dd, J = 6.6, 1.6 Hz, 3H).

C NMR (75 MHz, CDCl3): δ 164.8, 139.9, 138.8,
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135.9, 133.9, 133.0, 131.6, 129.3 (2C), 129.1 (2C), 128.9 (2C), 128.8 (2C), 128.2, 126.9, 125.1,
117.1, 72.1, 71.8, 18.1.

4-((phenylperoxy)thio)hexa-1,5-dien-3-yl

acrylate

(20g).

To

a

solution

of

(allylsulfonyl)benzene (300 mg, 1.65 mmol, 1.0 equiv.) in THF (3.67 mL) at -0°C was added nBuLi (1.6M, 1.03 mL, 1.65 mmol, 1.0 equiv.) and the mixture was stirred for 30 min before adding
acrolein (0.22 mL, 3.30 mmol, 2.0 equiv.) and stirring for 4 h at -50°C. Dropwise addition of
acryloyl chloride (0.52 mL, 6.45 mmol, 5.0 equiv.) was done at -50°C and the resulting mixture
was allowed to slowly warm to room temperature over 12 h. The reaction was quenched with aq.
NH4Cl (20 mL) and extracted with MTBE (2 x 20 mL). The combined organic extracts were dried
over MgSO4, filtered, and concentrated in vacuo. Purification by flash column chromatography on
silica (4:1 hexanes:ethyl acetate) gave compound 20g (0.38 g, 78%) as an inseparable mixture of
diastereomers.

1

H NMR (300 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.83 (d, J = 8.2 Hz, 2H), 7.79

(d, J = 7.6 Hz, 2H), 7.61-7.58 (m, 2H), 7.49 (dd, J = 16.3, 8.2 Hz, 4H), 6.44 (d, J = 17.4 Hz, 1H),
6.30 (t, J = 15.4 Hz, 2H), 6.06 (d, J = 7.7 Hz, 1H), 5.96-5.83 (m, 5H), 5.77 (d, J = 10.6 Hz, 2H),
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5.74 (m, 1H), 5.46 (d, J = 11.6 Hz, 1H), 5.37-5.20 (m, 6H), 5.07 (d, J = 18.3 Hz, 1H), 3.97 (dd, J
= 9.4, 6.7 Hz, 1H), 3.68 (d, J = 10.1 Hz, 1H).

5-(phenyl(phenylsulfonyl)methyl)furan-2(5H)-one (22a). To a solution of compound 20a (92
mg, 0.27 mmol, 1.0 equiv.) in toluene (17.9 mL) at 80 °C was added batchwise catalyst Ru-2 (3 x
6 mg, 0.075 equiv.) over 18 h. The reaction was then cooled to room temperature and concentrated
in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate)
gave compound 22a (54 mg, 64%) as an oil.

IR (ATR): 1749, 1314, 1147, 753, 727, 715 cm-1. 1H NMR (300 MHz, CDCl3) δ (signals for one
diastereomer) 7.93 (d, J = 9.5 Hz, 1H), 7.63-7.45 (m, 3H), 7.36 (t, J =12.9 Hz, 2H), 7.32-7.16 (m,
3H), 7.08 (d, J = 12.3 Hz, 2H), 6.17 (dd, J = 9.5, 2.7 Hz, 1H), 6.00 (d, J = 12.0 Hz, 1H), (d, J =
12.2 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ (signals for mixture of diastereomers) 171.6, 171.1,
154.4, 153.5, 137.8, 136.5, 134.2, 130.4, 130.0, 129.7, 129.5, 129.2, 129.0, 128.9, 128.8, 128.7,
127.7, 123.3, 122.6, 79.7, 79.6, 73.5, 72.8. TOFMS (ES+): m/z calcd for C17H14O4SNa [M + Na]+:
337.0511; found: 337.0519.
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5-(1-(phenylsulfonyl)ethyl)furan-2(5H)-one (22b). To a solution of compound 20b (203 mg,
0.69 mmol, 1.0 equiv.) in toluene (45.9 mL) at 80°C was added batchwise catalyst Ru-2 (3 x 15
mg, 0.075 equiv) over 18 h. The reaction was then cooled to room temperature and concentrated
in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate)
gave compound 22b (125 mg, 72%) as an oil.

Spectral data for the major isomer: IR (ATR): 1752, 1306, 1070, 1147, 1035, 739, 689, 589 cm-1.
1

H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.9 Hz, 2H), 7.77 (dd, J = 5.8, 1.4 Hz, 1H), 7.74 (t, J =

7.6 Hz, 1H), 7.63 (t, J = 7.9 Hz, 2H), 6.26 (dd, J = 5.8, 1.9 Hz, 1H), 5.60 (m, 1H), 3.71 (m, 1H),
1.10 (d, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 171.42, 153.16, 137.18, 134.55, 129.73,
128.73, 123.59, 79.08, 60.93, 7.74. TOFMS (ES+): m/z calcd for C12H12O4SNa [M + Na]+:
275.0354; found: 275.0346.

5-(2-methyl-1-(phenylsulfonyl)propyl)furan-2(5H)-one (22c). To a solution of compound 20c
(400 mg, 1.24 mmol, 1.0 equiv.) in toluene (82.7 mL) at 80 °C. was added batchwise catalyst Ru2 (3 x 31 mg, 0.075 equiv.) over 18 h. The reaction was then cooled to room temperature and
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concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1
hexanes:ethyl acetate) gave compound 22c (185 mg, 51%) as an oil.

IR (ATR): 1755, 1447, 1304, 1146, 892, 593, 556 cm-1. 1H NMR (500 MHz, CDCl3) δ (signals for
diastereomer α) 7.99 (dd, J = 5.8, 1.6 Hz, 1H), 7.88 (d, J = 7.9 Hz, 2H), 7.66-7.60 (m, 3H), 6.19
(dd, J = 5.8, 2.1 Hz, 1H), 5.47 (ddd, J = 6.8, 1.8, 1.8 Hz, 1H), 3.33 (dd, J = 6.8, 1.7 Hz, 1H), 2.44
(sepd, J = 7.0, 1.6 Hz, 1H), 1.22 (d, J = 7.2 Hz, 3H), 1.22 (d, J = 7.0 Hz, 3H). (signals for
diastereomer β) 7.96 (d, J = 8.6 Hz, 2H) 7.91 (dd, J = 5.8, 1.6 Hz, 1H), 7.75-7.70 (m, 3H). 6.24
(dd, J = 5.7, 2.0 Hz, 1H), 5.36 (ddd, J = 4.0, 4.0, 2.0 Hz, 1H), 3.57 (dd, J = 4.0, 2.3 Hz, 1H),
2.27(sepd, J = 7.1, 2.0 Hz, 1H), 1.24 (d, J = 7.1 Hz, 3H), 1.14 (d, J = 7.1 Hz, 3H). 13C NMR (125
MHz, CDCl3) δ (signals for one diastereomer) 171.5, 171.3, 155.4, 154.4, 139.2, 138.4, 134.3,
129.5, 128.4, 122.5, 121.8, 79.4, 78.6, 71.0, 70.4, 27.4, 26.1, 22.4, 21.1, 20.4, 17.3. TOFMS (ES+):
m/z calcd for C14H16O4SNa [M + Na]+: 303.0667; found: 303.0656.

5-(1-(phenylsulfonyl)pentyl)furan-2(5H)-one (22d). To a solution of compound 20d (100 mg,
0.297 mmol, 1.0 equiv.) in toluene (59.5 mL) at 80 oC was added batchwise catalyst Ru-2 (3 x 19
mg, 0.075 equiv.) over 18 h. The reaction was cooled to room temperature and concentrated in
vacuo. Purification by flash column chromatography on silica (10:1 to 4:1 to 1:1 hexanes: ethyl
acetate) gave compound 22d (50 mg, 62%) as an inseperable ~1:1 mixture of diastereomers.
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IR (ATR) 3021, 2959, 2872, 1757, 1146 cm-1. Spectral data for one diastereomer: 1H NMR
(500MHz, CDCl3): δ 7.90 (m, 2H), 7.73 (dd, J = 5.8, 1.5 Hz, 1H), 7.70 (td, J = 7.6, 1.3 Hz, 1H),
7.60 (m, 2H), 6.22 (dd, J = 5.8, 1.9 Hz, 1H), 5.47-5.46 (m, 1H), 3.54 (ddd, J = 5.9, 5.9, 3.7 Hz,
1H), 1.78 – 1.71 (m, 2H), 1.40 – 1.33 (m, 2H), 1.23 – 1.13 (m, 2H) 0.74 (t, J = 7.0 Hz, 3H).

13

C

NMR (75 MHz, CDCl3): δ 171.7, 153.7, 138.0, 134.7, 129.8 (2C), 128.8(2C), 123.7, 79.7, 65.5,
30.1, 23.5, 22.4, 13.7. TOFMS (ES+): m/z calcd for C15H18O4SNa [M + Na]+: 317.0823; found:
317.0829.

5-(3-phenyl-1-(phenylsulfonyl)propyl)furan-2(5H)-one (22e). To a solution of compound 20e
(330 mg, 0.86 mmol, 1.0 equiv.) in toluene (57 mL) at 80 °C was added batchwise catalyst Ru-2
(3 x 18.2 mg, 0.075 equiv.) over 18 h. The reaction was then cooled to room temperature and
concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1
hexanes:ethyl acetate) gave compound 22e (117 mg, 61%) as an oil.

IR (ATR): 1758, 1447, 1306, 1145, 728, 688 cm-1. 1H NMR (500 MHz, CDCl3) δ (signals for one
diastereomer) 7.86 (d, J = 7.9 Hz, 2H), 7.78 (dd, J = 5.8, 1.5 Hz, 1H), 7.73 (t, J = 7.5 Hz, 1H),
7.60 (t, J = 8.1 Hz, 2H), 7.24-7.15 (m, 3H), 7.97 (d, J = 7.6 Hz, 2H), 6.27 (dd, J = 5.8, 2.1 Hz,
1H), 5.51 (m, 1H), 3.6 (m, 1H), 2.60 (m, 2H), 2.08 (m, 1H), 1.71 (m, 1H).

13

C NMR (125 MHz,

CDCl3) δ (signals for one diastereomer) 171.4, 153.5, 139.2, 137.6, 134.5, 129.7, 128.6, 128.4,
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126.5, 123.7, 79.4, 63.7, 33.5, 25.0. TOFMS (ES+): m/z calcd for C19H18O4SNa [M + Na]+:
365.0823; found: 365.0815.

(E)-5-(3-phenyl-1-(phenylsulfonyl)allyl)furan-2(5H)-one (22f).To a solution of compound 20f
(279 mg, 0.729 mmol, 1.0 equiv.) in toluene (48.6 mL) at 80 oC was added batchwise catalyst Ru2 (3 x 16 mg, 0.075 equiv.) over 18 h. The reaction was cooled to room temperature and
concentrated in vacuo. Purification by flash column chromatography on silica (10:1 to 4:1 to 1:1
hexanes:ethyl acetate) gave compound 22f (190 mg, 76 %) as an inseparable ~1:1 mixture of
diastereomers.

IR (ATR) 3061, 2955, 1758, 1306, 1145, 1083 cm-1. Signals for one diastereomer: 1H NMR
(500MHz, CDCl3): δ 7.88 - 7.84 (m, 2H), 7.66-7.61 (m, 2H), 7.52 (t, J = 7.7 Hz, 2H), 7.28 – 7.25
(m, 3H), 7.20 – 7.16 (m, 2H), 6.26 – 6.23 (m, 2H), 5.82 (m, 1H), 5.77 (dd, J = 15.7, 10.1 Hz, 1H),
4.26 (dd, J = 10.2, 4.1 Hz, 1H).

C NMR (75 MHz, CDCl3): δ 171.3, 153.0, 141.8, 137.1, 135.0,

13

134.6, 129.3 (2C), 129.0, 128.9 (2C), 128.7 (2C), 126.8 (2C), 123.8, 113.7, 78.8, 70.8. TOFMS
(ES+): m/z calcd for C22H22O4SNa [M + Na]+: 405.1136; found: 405.1142.
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5-(1-(phenylsulfonyl)allyl)furan-2(5H)-one (22g).To a solution of compound 20g (100 mg,
0.342 mmol, 1.0 equiv.) in toluene (17.1 mL) at 80 oC was added batchwise catalyst Ru-2 (3 x 5.4
mg, 0.075 equiv.) over 18 h. The reaction was cooled to room temperature and concentrated in
vacuo. Purification by flash column chromatography on silica (10:1 to 4:1 to 1:1 hexanes:ethyl
acetate) gave compound 22g (78 mg, 86 %) as an inseparable ~1:1 mixture of diastereomers.

1

H NMR (500 MHz, CDCl3) δ (signals for one diastereomer) 7.87 (d, J = 7.6 Hz, 2H), 7.71-7.55

(m, 4H), 6.2 (d, J = 1.6 Hz, 1H), 5.73 (s), 5.58-5.46 (m, 1H), 5.38 (d, J = 10 Hz, 1H), 5.18 (d, J =
16 Hz, 1H), 3.79 (dd, J = 9.2 Hz, 1H).

(Z)-5-benzylidenefuran-2(5H)-one (28a). To a solution of compound 22a (34 mg, 0.11 mmol) in
DCM (1.5 mL) at room temperature was added triethylamine (0.090 mL, 0.65 mmol, 6.0 equiv.)
and the mixture was stirred for 15 h. The reaction was quenched with water (10 mL) and extracted
with DCM (2 x 10 mL). The organic extracts were dried over MgSO4, filtered, and concentrated
in vacuo. Putification by flash column chromatograhy on florisil (10:1 to 4:1 hexanes:ethyl acetate)
gave 28a (19 mg, 98%) as a 6:1 mixture of Z:E isomers. Spectral data for the major isomer matched
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that previously reported for (Z)-28a41: 1H NMR (300 MHz, CDCl3) δ 7.80 (d, J = 7.5 Hz, 2H),
7.50 (d, J = 5.3 Hz, 1H), 7.42-7.33 (m, 3H), 3.22 (d, J = 5.293 Hz, 1H), 6.04 (s, 1H).

(Z)-5-ethylidenefuran-2(5H)-one (28b). To a solution of compound 22b (106 mg, 0.42 mmol,
1.0 equiv.) in DCM (5.8 mL) at room temperature was added triethylamine (0.35 mL, 2.52 mmol)
and the mixture was stirred for 15 h. The reaction was quenched with water (10 mL) and extracted
with DCM (2 x 10 mL). The organic extracts were dried over MgSO4, filtered, and carefully
concentrated in vacuo (volatile compound) giving 28b as a 7:1 mixture of Z:E isomers. Spectral
data for the major isomer matched that previously reported for (Z)-28b42: 1H NMR (300MHz,
CDCl3) δ: 7.32 (d, J = 5.6 Hz, 1H), 6.15 (d, J = 5.4 Hz, 1H), 5.33 (q, J = 7.6 Hz, 1H), 1.98 (d, J =
8.3 Hz, 3H).

(Z)-5-(2-methylpropylidene)furan-2(5H)-one (28c). To a solution of compound 22c (166.2 mg,
0.59 mmol, 1.0 equiv.) in DCM (5.8 mL) at room temperature was added triethylamine (0.50 mL,
3.56 mmol, 6.0 equiv.) and the mixture was stirred for 15 h. The reaction was quenched with water
(10 mL) and extracted with DCM (2 x 10 mL). The organic extracts were dried over MgSO4,
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filtered, and carefully concentrated in vacuo. Putification by flash column chromatograhy on
florisil (4:1 hexanes:MTBE) gave 28c (76 mg, 95%) as a 4:1 mixture of Z:E isomers. Spectral
data for the major isomer matched that previously for the (Z)-28c.43

IR (ATR): 2963, 1770, 1749, 1556, 1135, 879 cm-1. 1H NMR (500 MHz, CDCl3) δ (signals for
major stereoisomer) 7.33 (d, J = 5.4 Hz, 1H), 6.17 (d, J = 5.5 Hz, 1H), 5.18 (d, J = 9.7 Hz, 1H),
3.05 (m, 1H), 1.13 (d, J = 6.8 Hz, 6H). (signals for minor stereoisomer) 7.66 (d, J = 5.6 Hz, 1H),
6.22 (dd, J = 5.6, 1.85 Hz, 1H), 5.67 (dd, J = 10.8, 1.8 Hz, 1H), 2.73 (m, 1H), 1.16 (d, J = 6.7 Hz,
6H). 13C NMR (125 MHz, CDCl3) δ (signals for mixture of diastereomers) 170.13, 148.0, 143.9,
139.6 124.3, 123.5, 120.1, 119.0, 29.8, 26.5, 23.4, 22.5. TOFMS (CI+): m/z calcd for C8H14O2N
[M + NH4]+: 156.1024; found: 156.1024.

(Z)-5-pentylidenefuran-2(5H)-one (28e). To a solution of compound 22e (32 mg, 0.107 mmol)
in DCM (2.0 mL) at room temperature was added triethylamine (0.1 ml, 0.64 mmol) and the
mixture was stirred for 15 h. The reaction was quenched with H2O (15 ml) and extracted with
MTBE (2 x 15 ml). The combined organic extracts were dried over MgSO4, filtered, and carefully
concentrated in vacuo. Purification by flash column chromatography on florisil (6:1
hexanes:methyl tert-butyl ether) gave compound 28e (17 mg, 100%) as an 8:1 mixture of Z:E
isomers. Spectral data for the major isomer matched that previously reported for the (Z)-28e.4
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Spectral data for the major isomer: IR (ATR) 3027, 2929, 2868, 1779, 1128 cm-1.

1

H NMR

(500MHz, CDCl3): δ 7.29 (d, J = 5.5 Hz, 1H), 6.12 (d, J = 5.4 Hz, 1H), 5.28 (t, J = 5.3 Hz, 1H),
2.39 (q, J = 7.6, 1.6, 1.6 Hz, 2H), 1.45 (quin, J = 7.1 Hz, 2H) 1.35 (sext, J = 7.2 Hz, 2H), 0.90 (t,
J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 170.4, 149.9, 143.8, 119.2, 118.0, 31.2, 26.4, 22.6,
14.0.

(Z)-5-(3-phenylpropylidene)furan-2(5H)-one (28d). To a solution of compound 22d (127 mg,
0.37 mmol, 1.0 equiv.) in DCM (7.4 mL) at room temperature was added triethylamine (0.31 mL,
2.22 mmol, 6.0 equiv.) and the mixture was stirred for 15 h. The reaction was quenched with water
(10 mL) and extracted with DCM (2 x 10 mL). The organic extracts were dried over MgSO4,
filtered, and concentrated in vacuo. Putification by flash column chromatograhy on florisil (4:1
hexanes:ethyl acetate) gave 22d (72 mg, 98%) as a 5:1 mixture of Z:E isomers.

Spectral data for the major isomer: IR (ATR): 1772, 1732, 1496, 1151, 1074, 700 cm-1. 1H NMR
(500 MHz, CDCl3) δ 7.35-7.30 (m, 3H), 7.26-7.23 (m, 3H), 6.18 (d, J = 5.5 Hz, 1H), 5.31 (t, J =
7.7 Hz, 1H), 2.86-2.75 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 170.0, 150.0, 143.5, 140.7, 128.5,
128.4, 126.3, 119.3, 116.2, 34.9, 27.9.
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(Z)-5-((E)-3-phenylallylidene)furan-2(5H)-one (28f).To a solution of compound 22f (32 mg,
0.107 mmol) in DCM (2.0 mL) at room temperature was added triethylamine (0.1 ml, 0.642 mmol)
and the mixture was stirred for 15 h. The reaction was quenched with H2O (15 ml) and extracted
with MTBE (2 x 15 ml). The combined organic extracts were dried over MgSO4, filtered, and
carefully concentrated in vacuo. Purification by flash column chromatography on florisil (6:1
hexanes:methyl tert-butyl ether) afforded compound 28f (17 mg, 98%) as a 3:1 mixture of Z:E
isomers.

Spectral data for the major isomer: IR (ATR) 3009, 2966, 1772, 1743, 1537, 1107 cm-1. 1H NMR
(500MHz, CDCl3): δ 7.25 (dd, J = 15.8, 11.4 Hz, 1H), 7.18 – 7.11 (m, 5H), 7.08-7.02 (m, 5H),
6.64 (d, J = 5.5 Hz, 1H), 6.48 (dd, J = 15.3, 11.7 Hz, 1H), 6.41 (d, J = 15.9 Hz, 1H), 6.32 (d, J =
5.3 Hz, 1H), 6.24 (d, J = 15.5 Hz, 1H), 6.01 (m, 1H), 5.56 (dd, J = 5.4, 1.9 Hz, 1H), 5.53 (d, J =
5.3, 1H), 5.22 (d, J = 11.5, 1H).

13

C NMR (75 MHz, CDCl3): 168.4, 150.8, 149.0, 141.9, 137.4,

137.0, 136.5, 136.4, 128.7 (2C), 128.6 (2C), 128.4, 128.0 (2C), 127.8, 125.6, 127.1 (2C), 126.7,
121.6, 120.9, 119.0, 118.4, 114.6, 113.7. TOFMS (ES+): m/z calcd for C13H10O2Na [M + Na]+:
221.0578; found: 221.0584.
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(Z)-5-allylidenefuran-2(5H)-one (28g). To a solution of compound 22g (38.8 mg, 0.140 mmol)
in DCM (2.0 mL) at room temperature was added triethylamine (0.12 ml, 0.88 mmol) and the
mixture was stirred for 15 h. The reaction was quenched with H2O (15 ml) and extracted with
MTBE (2 x 15 ml). The combined organic extracts were dried over MgSO4, filtered, and carefully
concentrated in vacuo. Purification by flash column chromatography on florisil (6:1
hexanes:methyl tert-butyl ether) afforded compound 28g (16 mg, 94%) as a 2:1 mixture of Z:E
isomers.

1

H NMR (300 MHz, CDCl3) δ (signals for one diastereomer) 7.38 (d, J = 5.6 Hz, 1H), 6.87 (dt, J

= 17.0, 10.7 Hz, 1H), 6.21 (d, J = 6.3 Hz, 1H), 5.83 (d, J = 11.3 Hz, 1H), 5.45 (d, J = 10.8 Hz,
2H).

Compound 73a. To a solution of ((3-phenylpropyl)sulfonyl)benzene (500 mg, 1.92 mmol, 1.0
equiv.) in THF (9.6 mL) at -78 °C was added n-BuLi (1.6 M,1.44 mL, 2.30 mmol, 1.2 equiv.) and
the mixture was stirred for 1 h before adding methacrolein (0.32 mL, 3.84 mmol, 2.0 equiv.) and
stirring for 10 min. The mixture was warmed to 0 °C followed by the addition of acryloyl chloride
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(0.31 mL, 3.84 mmol, 2.0 equiv.) and the mixture was allowed to slowly warm to room
temperature over 15 h. The reaction was quenched with aq. NH4Cl (20 mL) and extracted with
DCM (2 x 15 mL). The organic extracts were dried over MgSO4, filtered, and concentrated in
vacuo. Putification by flash column chromatograhy on silica (4:1 to 1:1 hexanes:ethyl acetate)
gave 73a (0.7 g, 92%) as an inseparable mixture of diastereomers.

Spectral data for the mixture of diastereomers: IR (ATR): 1728, 1305, 1174, 1142, 727, 690 cm. H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 7.6 Hz, 2H), 7.83 (d, J = 7.6 Hz, 2H), 7.63-7.57 (m,

1 1

3H), 7.53-7.48 (m, 3H), 7.27 (t, J = 7.4 Hz, 3H), 7.21-7.18 (m, 4H), 7.14 (d, J = 7.6 Hz, 3H), 6.25
(d, J = 19.5 Hz, 1H), 6.08 (d, J = 16.7 Hz, 1H), 5.89 (m , 1H), 5.76-5.56 (m, 5H), 5.14 (s, 1H),
5.08 (s, 1H), 4.87 (s, 1H), 4.79 (s, 1H), 3.53 (m, 1H), 3.17 (m, 1H), 2.97-2.83 (m, 4H), 2.32-2.02
(m, 4H), 1.54 (s, 3H), 1.32 (s, 3H).

C NMR (125 MHz, CDCl3) δ 164.0, 163.9, 140.8, 140.4,

13

140.3, 139.8, 139.2, 137.8, 134.0, 133.4, 131.6, 131.5, 129.3, 129.2, 129.0, 128.8, 128.6 (3C),
128.2, 127.6, 127.5, 126.4, 117.7, 112.6, 77.3, 75.6, 72.7, 64.1, 63.7, 33.7, 33.0, 27.6, 25.0, 19.0,
17.6. TOFMS (ES+): m/z calcd for C22H24O4SNa [M + Na]+: 407.1293; found: 407.1287.

4-methyl-5-(3-phenyl-1-(phenylsulfonyl)propyl)furan-2(5H)-one. To a solution of compound
73a (100.0 mg, 0.26 mmol, 1.0 equiv.) in toluene (17.3 mL) at 80 °C was added batchwise catalyst
Ru-1 (3 x 4 mg, 0.075 equiv.) over 18 h. The reaction was cooled to room temperature and
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concentrated in vacuo. Purification by flash chromatography on silica (4:1 to 1:1 hexanes:ethyl
acetate) gave the RCM product (45 mg, 49%) as an inseparable mixture of diastereomers.

To a solution of the RCM adduct above (56.0 mg, 0.16 mmol, 1.0 equiv.) in DCM (3.27 mL) at
room temperature was added triethylamine (0.14 mL, 6.0 equiv.) and the mixture was stirred for
15 h. The reaction was quenched with water (10 mL) and extracted with DCM (2 x 10 mL). The
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. Putification by flash
column chromatograhy on florisil (4:1 hexanes:ethyl acetate) gave the eliminated product (34 mg
100%) as a mixture of isomers.

Spectral data for the major isomer: IR (ATR): 1762, 920, 749, 699 cm-1. 1H NMR (500 MHz,
CDCl3) δ 7.32-7.20 (m, 5H), 5.90 (s, 1H), 5.30 (m, 1H), 2.80 (m, 2H), 2.72 (m, 2H), 2.11 (s, 3H).
C NMR (125 MHz, CDCl3) δ 169.4, 154.5, 151.0, 140.8, 128.5, 128.4, 126.2, 116.2, 111.8, 35.0,

13

27.7, 11.7. TOFMS (ES+): m/z calcd for C14H14O2Na [M + Na]+: 237.0891; found: 237.0887.

Compound 73b. To a solution of ((3-phenylpropyl)sulfonyl)benzene (300 mg, 1.15 mmol, 1.0
equiv.) in THF (5.8 mL) at -78 °C was added n-BuLi (1.6 M, 0.86 mL, 1.38 mmol, 1.2 equiv.) and
the mixture was stirred for 1 h before adding crotonaldehyde (0.19 mL, 2.30 mmol, 2.0 equiv.)
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and stirring for 10 min. The mixture was warmed to 0 °C followed by the addition of methacryloyl
chloride (0.23 mL, 2.30 mmol, 2.0 equiv.) and the mixture was allowed to slowly warm to room
temperature over 15 h. The reaction was quenched with aq. NH4Cl (20 mL) and extracted with
DCM (2 x 15 mL). The organic extracts were dried over MgSO4, filtered, and concentrated in
vacuo. Putification by flash column chromatograhy on silica (4:1 to 1:1 hexanes:ethyl acetate)
gave compound 73b (0.3 g, 65%) as an inseparable mixture of diastereomers.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.87-7.84 (m, 4 H), 7.64-

7.60 (m, 2H), 7.55-7.50 (m, 4H), 7.31-7.15 (m, 8H), 7.06 (d, J = 7.24 Hz, 2H), 5.89 (s, 2H), 5.875.80 (m, 2H), 5.71 (dd, J = 5.9, 5.6 Hz, 1H), 5.62-5.53 (m, 2H), 5.48 (s, 1H), 5.45 (s, 1H), 5.22
(dd, J = 15.3, 6.1 Hz, 1H), 3.42 (dt, J = 5.6, 5.6 Hz, 1H), 3.16 (t, J = 5.4 Hz, 1H), 2.97-2.81 (m,
3H), 2.73 (m, 1H), 2.39-2.28 (m, 2H), 2.22-2.10(m, 2H), 1.80 (s, 3H), 1.77, (s, 3H), 1.73, (d, J =
6.5 Hz, 3H), 1.62 (d, J = 6.5 Hz, 3H).

13

C NMR (125 MHz, CDCl3) δ (signals for mixture of

diastereomers) 165.6, 165.5, 140.4, 140.3, 139.3, 138.3, 133.8, 133.7, 131.9, 130.3, 129.2, 129.0,
128.7, 128.6, 128.4, 126.4, 126.3, 126.2, 126.1, 126.0, 124.7, 72.1, 71.1, 66.7, 65.6, 34.0, 33.3,
26.6, 25.7, 18.1, 18.0, 17.9, 17.7.
IR (ATR): 1717, 1447, 1305, 1143, 728, 689 cm-1
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(Z)-3-methyl-5-(3-phenylpropylidene)furan-2(5H)-one.

To a solution of compound 73b (100.0 mg, 0.25

mmol, 1.0 equiv.) in toluene (16.7 mL) at 80 °C was added batchwise catalyst Ru-1 (3 x 5 mg,
0.075 equiv.) over 18 h. The reaction was cooled to room temperature and concentrated in vacuo.
Purification by flash chromatography on silica (4:1 to 1:1 hexanes:ethyl acetate) gave the RCM
product (65 mg, 72%) as an inseparable mixture of diastereomers.

To a solution of the RCM adduct above (64.5 mg, 0.18 mmol, 1.0 equiv.) in DCM (2.51 mL) at
room temperature was added triethylamine (0.15 mL, 6.0 equiv.) and the mixture was stirred for
15 h. The reaction was quenched with water (10 mL) and extracted with DCM (2 x 10 mL). The
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. Purification by flash
column chromatograhy on florisil (4:1 hexanes:ethyl acetate) gave the eliminated product (31 mg
79%) as a mixture of isomers.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers)7.31-7.26 (m, 4H), 7.22-7.19

(m, 4H), 7.14 (d, J = 7.4 Hz, 2H), 7.10 (s, 1H), 6.95 (s, 1H), 5.64 (t, J = 8.5 Hz, 1H), 5.13 (t, J =
7.7 Hz, 1H), 2.80-2.69 (m, 6H), 2.54 (dt, J = 7.8 Hz, 2H), 1.99 (s, 1H), 1.97(s, 1H). 13C NMR (125
MHz, CDCl3) δ (signals for mixture of diastereomers)171.1, 170.9, 149.1, 148.6, 140.8, 140.4,
137.6, 133.5, 130.4, 129.3, 128.5, 128.4, 126.3, 126.1, 113.2, 112.3, 36.0, 35.1, 28.4, 27.6, 10.7,
10.5.
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(E)-7-((tert-butyldimethylsilyl)oxy)-5-(phenylsulfonyl)hept-2-en-4-ol

(93).

tert-

butyldimethyl(3-(phenylsulfonyl)propoxy)silane (92) (210.4 mg, 0.67 mmol, 1.0 equiv.) was
added to a 10-mL shlenk tube and dissolved in THF (3.34 mL, 0.20 M) at -78°C. n-BuLi (0.32
mL, 0.80 mmol, 1.2 equiv.) was added drop wise and stirred for 1 h. Crotonaldehyde (0.11 mL,
1.34 mmol, 2.0 equiv.) was then added drop wise and continued to stir for 10 min. The reaction
was then quenched with water and extracted with MTBE. Purification by column chromatography
on silica (10:1 hexanes:ethyl acetate) gave product 93 (182.6 mg, 71%) as a mixture.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.90-7.87 (m, 4H), 7.67-

7.63 (m, 2H), 7.58-7.54 (m, 4H), 5.78-5.68 (m, 2H), 5.51 (dd, J = 15.4, 6.4 Hz, 1H), 5.38 (dd, J =
15.3, 5.5 Hz, 1H), 4.67 (d, J = 4.7 Hz, 1H), 4.49 (s, 1H), 3.97 (s, 1H), 3.69-3.63 (m, 2H), 3.563.51 (m, 2H), 3.37 (m, 1H), 3.32 (m, 1H), 2.09-2.01 (m, 2H), 1.89 (m, 1H), 1.67 (d, J = 6.5 Hz,
3H), 1.65 (d, J = 6.8 Hz, 3H), 0.83 (s, 9H), 0.82 (s, 9H), -0.02 (m, 12H). 13C NMR (125 MHz,
CDCl3) δ 138.5, 138.2, 133.9, 133.8, 129.5, 129.4, 129.3, 129.2, 128.7, 128.6, 128.4, 70.5, 69.2,
66.7, 64.7, 60.8, 60.2, 28.2, 25.9, 25.8, 25.7, 18.2, 18.1, 17.7, 17.6, -5.5, -5.6.
IR (ATR): 2954, 2929, 2884, 2856, 1472, 1447, 1287, 1254, 1144, 1082, 966, 833, 776, 723, 688
cm-1
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(E)-7-((tert-butyldimethylsilyl)oxy)-5-(phenylsulfonyl)hept-2-en-4-yl acrylate (94). DCM
(2.38

mL,

0.20

M)

was

used

to

transfer

(E)-7-((tert-butyldimethylsilyl)oxy)-5-

(phenylsulfonyl)hept-2-en-4-ol (93) (182.6 mg, 0.48 mmol, 1.0 equiv.) to a 10-mL shlenk tube.
The mixture was cooled to 0°C and Triethylamine (0.10 mL, 0.71 mmol, 1.5 equiv.) was added.
The reaction mixture continued to stir for 15 min. Acryloyl Chloride (0.05 mL, 0.57 mmol, 1.2
equiv.) was then added dropwise to the mixture to stir for 1 h. The reaction was quenched at 0°C
with Sodium Bicarbonate and extracted with DCM. Purification by column chromatography on
silica (10:1 hexanes:ethyl acetate) gave product 94 (98.5 mg, 46%) as a mixture.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.88 (d, J = 7.9 Hz, 2 H),

7.85 (d, J = 8.0 Hz, 2H), 7.64-7.59 (m, 2H), 7.56-7.51 (m, 4H), 6.28-6.20 (m, 2H), 5.87-5.79 (m,
3H), 5.75-5.66 (m, 3H), 5.58 (dd, J = 15.2, 7.1 Hz, 1H), 5.42 (dd, J = 15.1, 6.2 Hz, 1H), 3.83-3.67
(m, 5H), 3.46 (m, 1H), 2.26-2.15 (m, 3H), 2.09 (m, 1H), 2.00-1.93 (m, 2H), 1.71 (d, J = 6.4 Hz,
3H), 1.65 (d, J = 6.4 Hz, 1H), 0.87 (s, 9H), 0.82 (s, 9H), 0.04 (s, 3H), -0.01 (s, 6H), -0.03 (s, 3H).
C NMR (125 MHz, CDCl3) δ 164.4, 164.4, 139.7, 138.5, 133.7, 133.6, 132.1, 131.3, 131.1,

13

130.8, 129.2, 129.1, 128.9, 128.5, 128.0, 127.9, 126.0, 124.9, 72.1, 71.2, 63.8, 62.8, 60.2, 59.9,
28.0, 27.3, 25.8, 18.2, 18.1, 17.8, 17.7, -5.4, -5.5.
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(Z)-5-(3-((tert-butyldimethylsilyl)oxy)propylidene)furan-2(5H)-one (96). To a solution of
compound 94 (98.5 mg, 0.22 mmol, 1.0 equiv.) in toluene (14.5 mL) at 80 °C was added batchwise
catalyst Ru-1 (3 x 4 mg, 0.075 equiv.) over 18 h. The reaction was cooled to room temperature
and concentrated in vacuo. Purification by column chromatography on silica (4:1 to 1:1
hexanes:ethyl acetate) gave product 95 (63.7 mg, 74%) as an inseparable mixture of diastereomers.

To a solution of the RCM adduct above (95) (63.7 mg, 0.16 mmol, 1.0 equiv.) in DCM (2.22 mL)
at room temperature was added triethylamine (0.13 mL, 6.0 equiv.) and the mixture was stirred for
15 h. The reaction was quenched with water (10 mL) and extracted with DCM (2 x 10 mL). The
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. The crude product
96 was taken into the next step without purification.

1

H NMR (500 MHz, CDCl3) δ (signals for major diastereomer) 7.34 (d, J = 5.8Hz, 1H), 6.16 (d,

J = 5.4 Hz, 1H), 5.41 (t, J = 3.74 (t, J = 6.2 Hz, 2H), 2.63-2.59 (m, 2H), 0.88 (s, 9H), 0.05 (s, 6H).
(signals for minor diastereomer)7.63 (d, J = 6.3 Hz, 1H), 6.20 (d, J = 5.4 Hz, 1H), 5.79 (t, J = 8.3
Hz, 1H), 3.71 (t, J = 6.4 Hz, 2H), 2.47 (m, 2H), 0.86 (s, 9H), 0.03 (s, 6H). 13C NMR (125 MHz,
CDCl3) δ (signals for mixture of diastereomers) 170.0, 151.1, 150.3, 143.5, 140.0, 120.2, 119.3,
114.3, 113.2, 61.7, 45.8, 30.1, 29.8, 25.9, 25.8, 18.3, 18.2, 8.6, -5.3, -5.4.
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1,6-dioxaspiro[4.4]non-3-en-2-one (97). Compound 96 (31.4 mg, 0.12 mmol, 1.0 equiv.) was
transferred to a 25-mL round bottom with THF (4.97 mL, 0.024 M). LiOH (4.97 mL) was added
slowly and left to stir for 2 h at room temperature. The reaction mixture was then cooled to 0°C.
HF-Pyridine (1.25 mL, 70% HF, 0.011M) was then slowly added and left to stir overnight. The
reaction mixture was then slowly quenched with Sodium Bicarbonate at 0°C and extracted with
Ethyl Acetate affording the product (17.24 mg, 100% (via nmr)). Spectral data matched that
previously reported for 9744. 1H NMR (500 MHz, CDCl3) δ 7.13 (d, J= 5.5 Hz, 1H), 6.14 (d, J=
5.6 Hz, 1H), 4.26 (m, 1H), 4.12 (m, 1H), 2.36-2.12 (m, 4H). 13C NMR (125 MHz, CDCl3) 169.9,
151.8, 124.3, 114.5, 70.6, 35.4, 24.2.

(E)-8-((tert-butyldimethylsilyl)oxy)-5-(phenylsulfonyl)oct-2-en-4-ol

(106).

tert-

butyldimethyl(4-(phenylsulfonyl)butoxy)silane (105) (263.0 mg, 0.80 mmol, 1.0 equiv.) was
added to a 10-mL shlenk tube and dissolved in THF (4.01 mL, 0.20 M) at -78°C. n-BuLi (0.38
mL, 0.96 mmol, 1.2 equiv.) was added drop wise and stirred for 1 h. Crotonaldehyde (0.13 mL,
1.60 mmol, 2.0 equiv.) was then added drop wise and continued to stir for 10 min. The reaction
was then quenched with water and extracted with MTBE. Purification by column chromatography
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on silica (10:1 hexanes:ethyl acetate) gave product 106 (245.0 mg, 79%) as an inseparable mixture
of diastereomers.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.91-7.88 (m, 4H), 7.65 (m,

2H), 7.58-7.54 (m, 4H), 5.78-5.70 (m, 2H), 5.48-5.43 (m, 2H), 4.65 (d, J = 4.8 Hz, 1H), 4.47 (dd,
J = 8.1 Hz, 1H), 3.52-3.46 (m, 4H), 3.17 (dd, J = 12.3, 5.8 Hz, 1H), 3.09 (t, J = 5.0 Hz, 1H), 1.971.83 (m, 2H), 1.75 (m, 1H), 1.67 (d, J = 6.2 Hz, 6H), 1.64-1.47 (m, 5H), 0.84 (s, 18H), 0.02 (s,
12H). 13C NMR (125 MHz, CDCl3) δ (signals for mixture of diastereomers) 138.5, 138.2, 133.9,
133.8, 129.9, 129.4, 129.3, 129.1, 128.9, 128.8, 128.7, 128.6, 71.5, 69.6, 69.0, 68.7, 62.4, 31.3,
30.4, 25.9, 23.0, 19.8, 18.2, 17.7, -5.4.

(E)-8-((tert-butyldimethylsilyl)oxy)-5-(phenylsulfonyl)oct-2-en-4-yl

methacrylate

(107).

DCM (3.15 mL, 0.20 M) was used to transfer (E)-8-((tert-butyldimethylsilyl)oxy)-5(phenylsulfonyl)oct-2-en-4-ol (106) (251.3 mg, 0.63 mmol, 1.0 equiv.) to a 10-mL shlenk tube.
The mixture was cooled to 0°C and Triethylamine (0.13 mL, 0.95 mmol, 1.5 equiv.) was added.
The reaction mixture continued to stir for 15 min. Methacryloyl Chloride (0.12 mL, 1.26 mmol, 2
equiv.) was then added dropwise to the mixture to stir for 3 h. The reaction was quenched at 0°C
with Sodium Bicarbonate and extracted with DCM. The crude product was then purified using
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column chromatography on silica affording the product 107 (160.8 mg, 57%) as an inseparable
mixture of diastereomers.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.88 (d, J = 7.6 Hz, 2H), 7.85

(d, J = 7.7 Hz, 2H), 7.67-7.58 (m, 2H), 7.56-7.50 (m, 4H), 5.91 (s, 1H), 5.97 (s, 1H), 5.85-5.77
(m, 2H), 5.77-5.73 (m, 2H), 5.56 (dd, J = 15.4, 7.0 Hz, 1H), 5.47 (s, 1H), 5.43 (dd, J = 14.8, 7.3
Hz, 1H), 5.42 (s, 1H), 3.58 (m, 2H), 3.56 (m, 2H), 3.43 (m, 1H), 3.21 (m, 1H), 2.07-1.79 (m, 8H),
1.81 (s, 3H), 1.74 (s, 3H), 1.71 (d, J = 6.3 Hz, 3H), 1.67 (d, J = 6.6 Hz, 3H), 0.88 (s, 9H), 0.86 (s,
9H), 0.04 (s, 6H), 0.01 (s, 6H).

C NMR (125 MHz, CDCl3) δ (signals for mixture of

13

diastereomers) 165.6, 165.5, 139.4, 138.3, 133.6, 133.5, 132.0, 130.8, 129.1, 129.0, 128.6, 126.1,
126.0, 124.7, 72.2, 71.5, 68.2, 66.9, 62.5, 62.4, 31.3, 30.5, 25.8, 21.9, 21.2, 18.2, 18.1, 18.0, 17.8,
17.7, -5.4.

(Z)-5-(4-((tert-butyldimethylsilyl)oxy)butylidene)-3-methylfuran-2(5H)-one. (109). (E)-8((tert-butyldimethylsilyl)oxy)-5-(phenylsulfonyl)oct-2-en-4-yl methacrylate (107) (143.8 mg,
0.31 mmol, 1.0 equiv.) was added to a 25-mL shlenk tube with toluene (20.53 mL, 0.015 M) and
heated to 80°C. Ru-1 (4.83 mg, 0.0077 mmol, 0.025 equiv.) was then added to the mixture in four
hour increments two times and left to stir overnight. The crude product was then purified using
column chromatography on silica affording the product 108 (53.3 mg, 62 %) as a mixture.
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To a solution of the RCM adduct above (108) (53.3 mg, 0.13 mmol, 1.0 equiv.) in DCM (1.75 mL)
at room temperature was added triethylamine (0.11 mL, 6.0 equiv.) and the mixture was stirred for
15 h. The reaction was quenched with water (10 mL) and extracted with DCM (2 x 10 mL). The
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. The crude product
was then purified using column chromatography on silica affording the product 109 (26.1 mg, 71
%) as a mixture.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.30 (s, 1H), 6.97 (s, 1H),

5.62 (t, J = 8.8 Hz, 1H), 5.17 (t, J = 7.5 Hz, 1H), 3.66-3.61 (m, 4H), 2.44 (dt, J = 7.7 Hz, 2H), 2.34
(dt, J = 7.3 Hz, 2H), 2.00 (d, J = 10.5 Hz, 6H), 1.67 (m, 4H), 0.88 (s, 18H), 0.05 (s, 12H).

3-methyl-1,6-dioxaspiro[4.5]dec-3-en-2-one (110). Compound 109 (53.0 mg, 0.19 mmol, 1.0
equiv.) was transferred to a 25-mL round bottom with THF (7.82 mL, 0.024 M). LiOH (7.82 mL)
was added slowly and left to stir for 2 h at room temperature. The reaction mixture was then cooled
to 0°C. HF-Pyridine (1.95 mL, 70% HF, 0.011M) was then slowly added and left to stir overnight.
The reaction mixture was then slowly quenched with Sodium Bicarbonate at 0°C and extracted
with Ethyl Acetate affording the product 110 (24.6 mg, 77%).
78

1

H NMR (500 MHz, CDCl3) δ 6.74 (s, 1H), 4.01 (t, J = 10.5 Hz, 1H), 3.89 (d, J = 12.8 Hz, 1H),

1.90 (s, 3H), 1.85-1.79 (m, 2H), 1.72-1.63 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 172.0, 147.2,
131.9, 104.8, 65.0, 32.3, 24.1, 19.1, 10.5.

1-phenyl-1-((phenylperoxy)thio)but-3-en-2-yl 2-bromoacrylate (77). To a solution of 1phenyl-1-(phenylsulfonyl)but-3-en-2-ol (0.40 g, 1.40 mmol) in DCM (7.0 mL) at 0°C was added
triethylamine (0.29 mL, 2.10 mmol, 1.5 equiv.) followed by compound 7645 (0.28 mg, 1.68 mmol,
1.2 equiv.) for 1 h. The reaction was quenched with aq. sodium bicarbonate (20 mL) and extracted
with DCM (2 x 20 mL). The combined organic extracts were dried over MgSO4, filtered, and
concentrated in vacuo. Purification by flash column chromatography on silica (4:1 to 1:1
hexanes:ethyl acetate) gave compound 77 (0.29 g, 49%) as an inseparable mixture of
diastereomers.

1

H NMR (500 MHz, CDCl3) δ (signals for mixture of diastereomers) 7.60 (d, J = 7.6 Hz, 2H),

7.55-7.48 (m, 4H), 7.39-7.22 (m, 12H), 7.18 (d, J = 7.5 Hz, 2H) 6.96 (s, 1H), 6.94 (s, 1H), 6.35
(m, 1H), 6.28-6.25 (m, 3H), 5.64 (m, 2H), 5.39-5.13 (m, 4H), 4.54 (d, J = 9.2 Hz, 1H), 4.28 (d, J
= 4.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ (signals for mixture of diastereomers) 160.4, 160.3,
138.7, 137.8, 133.8, 133.6, 132.2, 132.0, 131.7, 131.6, 131.2, 130.6, 129.8, 129.3, 129.2, 129.0,
128.9, 128.8, 128.7, 128.6, 128.4, 120.7, 120.6, 120.5, 74.7, 73.7, 73.2.
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